Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Osteoporosis

  Free Subscription


Articles published in Osteoporos Int

Retrieve available abstracts of 397 articles:
HTML format



Single Articles


    December 2022
  1. LANGDAHL B, Hofbauer LC, Ferrari S, Wang Z, et al
    Romosozumab efficacy and safety in European patients enrolled in the FRAME trial.
    Osteoporos Int. 2022;33:2527-2536.
    PubMed     Abstract available


  2. HANS D, Shevroja E, McDermott M, Huang S, et al
    Updated trabecular bone score accounting for the soft tissue thickness (TBSTT) demonstrated significantly improved bone microstructure with denosumab in the FREEDOM TBS post hoc analysis.
    Osteoporos Int. 2022;33:2517-2525.
    PubMed     Abstract available


    November 2022
  3. DING BTK, Lim HF, Johari F, Kunnasegaran R, et al
    An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures.
    Osteoporos Int. 2022 Nov 21. doi: 10.1007/s00198-022-06595.
    PubMed     Abstract available


  4. PERIS P, Monegal A, Makitie RE, Guanabens N, et al
    Osteoporosis related to WNT1 variants: a not infrequent cause of osteoporosis.
    Osteoporos Int. 2022 Nov 18. pii: 10.1007/s00198-022-06609.
    PubMed     Abstract available


  5. GAO SS, Zhao Y
    The effects of beta-carotene on osteoporosis: a systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2022 Nov 16. pii: 10.1007/s00198-022-06593.
    PubMed     Abstract available


  6. BINKLEY N, Schousboe JT, Lix LM, Morin SN, et al
    Should vertebral fracture assessment be performed in Fracture Liaison Service patients with non-vertebral fracture?
    Osteoporos Int. 2022 Nov 16. pii: 10.1007/s00198-022-06586.
    PubMed     Abstract available


  7. PARASKEVOPOULOS K, Keskinis A, Vasios IS, Makiev KG, et al
    Comparison of various treatment modalities for the management of bone marrow edema syndrome/transient osteoporosis in men and non-pregnant women: a systematic review.
    Osteoporos Int. 2022 Nov 12. pii: 10.1007/s00198-022-06584.
    PubMed     Abstract available


  8. DUARTE MP, Ribeiro HS, Neri SGR, Almeida LS, et al
    Prevalence of low bone mineral density (T-score
    Osteoporos Int. 2022 Nov 12. pii: 10.1007/s00198-022-06598.
    PubMed     Abstract available


  9. JACOBSON BENSKY M, Adler L, Banon T, Gabay L, et al
    Risk of major osteoporotic fractures among ultra-orthodox Jews.
    Osteoporos Int. 2022 Nov 11. pii: 10.1007/s00198-022-06522.
    PubMed     Abstract available


  10. MENGEL E, Tamme R, Remmel L, Purge P, et al
    Pubertal increment in insulin resistance is negatively related to lumbar bone mineral density in 18-year-old males.
    Osteoporos Int. 2022 Nov 11. pii: 10.1007/s00198-022-06591.
    PubMed     Abstract available


  11. HOFFMANN I, Kohl M, von Stengel S, Jakob F, et al
    Exercise and the prevention of major osteoporotic fractures in adults: a systematic review and meta-analysis with special emphasis on intensity progression and study duration.
    Osteoporos Int. 2022 Nov 10. pii: 10.1007/s00198-022-06592.
    PubMed     Abstract available


  12. AALTONEN HL, O'Reilly MK, Linnau KF, Dong Q, et al
    m2ABQ-a proposed refinement of the modified algorithm-based qualitative classification of osteoporotic vertebral fractures.
    Osteoporos Int. 2022 Nov 7. pii: 10.1007/s00198-022-06546.
    PubMed     Abstract available


  13. PHUNG K, McAdam L, Ma J, McMillan HJ, et al
    Risk factors associated with prevalent vertebral fractures in Duchenne muscular dystrophy.
    Osteoporos Int. 2022 Nov 7. pii: 10.1007/s00198-022-06578.
    PubMed     Abstract available


  14. DWIVEDI R, Mishra L, Ghobrial H, Abbas H, et al
    Prevalent vertebral fractures in patients admitted with acute hip fracture.
    Osteoporos Int. 2022 Nov 7. pii: 10.1007/s00198-022-06564.
    PubMed    


  15. KOH AJ, Nam HK, Michalski MN, Do J, et al
    Anabolic actions of parathyroid hormone in a hypophosphatasia mouse model.
    Osteoporos Int. 2022;33:2423-2433.
    PubMed     Abstract available


  16. SALE JEM, Yang A, Inrig T, Gandhi S, et al
    Patients not taking a previously prescribed bone active medication now prescribed medication through Ontario FLS.
    Osteoporos Int. 2022;33:2435-2440.
    PubMed     Abstract available


    October 2022
  17. KANIS JA, McCloskey EV, Harvey NC, Cooper C, et al
    The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis.
    Osteoporos Int. 2022 Oct 25. pii: 10.1007/s00198-022-06567.
    PubMed     Abstract available


  18. DE OLIVEIRA RDJ, de Oliveira RG, de Oliveira LC, Santos-Filho SD, et al
    Effectiveness of whole-body vibration on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2022 Oct 25. pii: 10.1007/s00198-022-06556.
    PubMed     Abstract available


  19. KIM J, Ha J, Jeong C, Lee J, et al
    Bone mineral density and lipid profiles in older adults: a nationwide cross-sectional study.
    Osteoporos Int. 2022 Oct 18. pii: 10.1007/s00198-022-06571.
    PubMed     Abstract available


  20. POORIRANI S, Taheri SL, Mostafavi SA
    Scaffolds: a biomaterial engineering in targeted drug delivery for osteoporosis.
    Osteoporos Int. 2022 Oct 15. pii: 10.1007/s00198-022-06543.
    PubMed     Abstract available


  21. MORI S, Hagino H, Sugimoto T, Tanaka S, et al
    Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05.
    Osteoporos Int. 2022 Oct 14. pii: 10.1007/s00198-022-06570.
    PubMed     Abstract available


  22. LAIRD C, Benson H, Williams KA
    Pharmacist interventions in osteoporosis management: a systematic review.
    Osteoporos Int. 2022 Oct 14. pii: 10.1007/s00198-022-06561.
    PubMed     Abstract available


  23. HUANG YP, Chen LS, Feng SH, Liang YS, et al
    Tea consumption and the risks of osteoporosis and hip fracture: a population-based longitudinal follow-up study.
    Osteoporos Int. 2022 Oct 14. pii: 10.1007/s00198-022-06569.
    PubMed     Abstract available


  24. ZHOU C
    Reply to comments on "Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis".
    Osteoporos Int. 2022 Oct 13. pii: 10.1007/s00198-022-06331.
    PubMed    


  25. KHOURI C, Lepelley M, Mallaret M
    Comment on Zhou et al.: Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.
    Osteoporos Int. 2022 Oct 13. pii: 10.1007/s00198-022-06507.
    PubMed    


  26. KOO HY, Cho EB, Kong SH, Han K, et al
    Fracture risk in Parkinson's disease according to its severity and duration.
    Osteoporos Int. 2022 Oct 7. pii: 10.1007/s00198-022-06562.
    PubMed     Abstract available


  27. TIFTIK T, Kara M, Koyuncu EG, Kaymak B, et al
    The relationship between sarcopenia-related measurements and osteoporosis: The SARCOP study.
    Osteoporos Int. 2022 Oct 4. pii: 10.1007/s00198-022-06563.
    PubMed     Abstract available


    September 2022
  28. HE Y, Chen Y
    The potential mechanism of the microbiota-gut-bone axis in osteoporosis: a review.
    Osteoporos Int. 2022 Sep 28. pii: 10.1007/s00198-022-06557.
    PubMed     Abstract available


  29. SHABANI F, Tsinaslanidis G, Thimmaiah R, Khattak M, et al
    Correction to: Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care.
    Osteoporos Int. 2022 Sep 23. pii: 10.1007/s00198-022-06440.
    PubMed    


  30. EBINA K, Etani Y, Tsuboi H, Nagayama Y, et al
    Impact of the duration of previous osteoporosis treatment on the effect of romosozumab in patients with postmenopausal osteoporosis.
    Osteoporos Int. 2022 Sep 6. pii: 10.1007/s00198-022-06545.
    PubMed    


    August 2022
  31. MORIN SN, Berger C, Papaioannou A, Cheung AM, et al
    Race/ethnic differences in the prevalence of osteoporosis, falls and fractures: a cross-sectional analysis of the Canadian Longitudinal Study on Aging.
    Osteoporos Int. 2022 Aug 31. pii: 10.1007/s00198-022-06539.
    PubMed     Abstract available


  32. BOKRANTZ T, Manhem K, Lorentzon M, Karlsson M, et al
    The association between peripheral arterial disease and risk for hip fractures in elderly men is not explained by low hip bone mineral density. Results from the MrOS Sweden study.
    Osteoporos Int. 2022 Aug 19. pii: 10.1007/s00198-022-06535.
    PubMed     Abstract available


  33. SUZUKI T, Mizobuchi M, Yoshida S, Terado N, et al
    Romosozumab successfully regulated progressive osteoporosis in a patient with autosomal dominant polycystic kidney disease undergoing hemodialysis.
    Osteoporos Int. 2022 Aug 18. pii: 10.1007/s00198-022-06534.
    PubMed     Abstract available


  34. YANG J, Liao M, Wang Y, Chen L, et al
    Opportunistic osteoporosis screening using chest CT with artificial intelligence.
    Osteoporos Int. 2022 Aug 6. pii: 10.1007/s00198-022-06491.
    PubMed     Abstract available


  35. CHIAPPARELLI E, Okano I, Adl Amini D, Zhu J, et al
    The association between lumbar paraspinal muscle functional cross-sectional area on MRI and regional volumetric bone mineral density measured by quantitative computed tomography.
    Osteoporos Int. 2022 Aug 6. pii: 10.1007/s00198-022-06430.
    PubMed     Abstract available


  36. SHIN JW, He Q, Suk YJ, Kim SH, et al
    Comparison of the efficacy between sequential therapy with teriparatide and denosumab and denosumab monotherapy in suppressing fragility fracture risk.
    Osteoporos Int. 2022 Aug 4. pii: 10.1007/s00198-022-06495.
    PubMed     Abstract available


  37. LU K, Shi Q, Gong YQ, Shao JW, et al
    Predicting the acute-phase response fever risk in bisphosphonate-naive osteoporotic patients receiving their first dose of zoledronate.
    Osteoporos Int. 2022 Aug 3. pii: 10.1007/s00198-022-06493.
    PubMed     Abstract available


  38. LIPPUNER K, Rimmer G, Stuck AK, Schwab P, et al
    Hospitalizations for major osteoporotic fractures in Switzerland: a long-term trend analysis between 1998 and 2018.
    Osteoporos Int. 2022 Aug 2. pii: 10.1007/s00198-022-06481.
    PubMed     Abstract available


  39. COSMAN F, Cooper C, Wang Y, Mitlak B, et al
    Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database study.
    Osteoporos Int. 2022;33:1703-1714.
    PubMed     Abstract available


    July 2022
  40. GRIMBLY C, Escagedo PD, Jaremko JL, Bruce A, et al
    Sickle cell bone disease and response to intravenous bisphosphonates in children.
    Osteoporos Int. 2022 Jul 29. pii: 10.1007/s00198-022-06455.
    PubMed     Abstract available


  41. LEBOFF MS, Greenspan SL, Insogna KL, Lewiecki EM, et al
    Correction to: The clinician's guide to prevention and treatment of osteoporosis.
    Osteoporos Int. 2022 Jul 28. pii: 10.1007/s00198-022-06479.
    PubMed    


  42. TARANTINO U, Cariati I, Greggi C, Iundusi R, et al
    Gaps and alternative surgical and non-surgical approaches in the bone fragility management: an updated review.
    Osteoporos Int. 2022 Jul 18. pii: 10.1007/s00198-022-06482.
    PubMed     Abstract available


  43. PUENTE N, Vega AI, Hernandez JL, Fernandez-Luna JL, et al
    An LRP6 mutation (Arg360His) associated with low bone mineral density but not cardiovascular events in a Caucasian family.
    Osteoporos Int. 2022 Jul 15. pii: 10.1007/s00198-022-06494.
    PubMed     Abstract available


  44. LORENTZON M, Johansson H, Harvey NC, Liu E, et al
    Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability-results from the Women's Health Initiative hormone therapy trials.
    Osteoporos Int. 2022 Jul 14. pii: 10.1007/s00198-022-06483.
    PubMed     Abstract available


  45. XIAO PL, Fuerwa C, Hsu CJ, Peng R, et al
    Socioeconomic status influences on bone mineral density in American men: findings from NHANES 2011-2020.
    Osteoporos Int. 2022 Jul 14. pii: 10.1007/s00198-022-06498.
    PubMed     Abstract available


  46. FIXEN CW, Fixen DR
    Renal safety of zoledronic acid for osteoporosis in adults 75 years and older.
    Osteoporos Int. 2022 Jul 13. pii: 10.1007/s00198-022-06499.
    PubMed     Abstract available


  47. ZHANG F, Zhou F, Liu H, Zhang X, et al
    Long-term exposure to air pollution might decrease bone mineral density T-score and increase the prevalence of osteoporosis in Hubei province: evidence from China Osteoporosis Prevalence Study.
    Osteoporos Int. 2022 Jul 13. pii: 10.1007/s00198-022-06488.
    PubMed     Abstract available


  48. OSTOVAR A, Mousavi A, Sajjadi-Jazi SM, Rajabi M, et al
    The economic burden of osteoporosis in Iran in 2020.
    Osteoporos Int. 2022 Jul 11. pii: 10.1007/s00198-022-06484.
    PubMed     Abstract available


  49. BELAYA Z, Melnichenko G, Golounina O, Tsoriev T, et al
    Correction: Three-year progress report of Bone Health TeleECHO Moscow: a strategy to improve the care of patients with osteoporosis and other metabolic skeletal diseases in underserved communities of Russia.
    Osteoporos Int. 2022 Jul 7. pii: 10.1007/s00198-022-06469.
    PubMed    


  50. FUJIWARA S, Buchanan-Hughes A, Ng A, Page J, et al
    Real-world evaluation of osteoporotic fractures using the Japan Medical Data Vision database.
    Osteoporos Int. 2022 Jul 2. pii: 10.1007/s00198-022-06472.
    PubMed     Abstract available


  51. HA J, Kim J, Jeong C, Lim Y, et al
    Effect of follow-up raloxifene therapy after denosumab discontinuation in postmenopausal women.
    Osteoporos Int. 2022;33:1591-1599.
    PubMed     Abstract available


    June 2022
  52. TRAN O, Silverman S, Xu X, Bonafede M, et al
    Correction to: Long-term direct and indirect economic burden associated with osteoporotic fracture in US postmenopausal women.
    Osteoporos Int. 2022 Jun 29. pii: 10.1007/s00198-022-06410.
    PubMed    


  53. PAN B, Cai J, Zhao P, Liu J, et al
    Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Osteoporos Int. 2022 Jun 28. pii: 10.1007/s00198-022-06459.
    PubMed     Abstract available


  54. MCCLOSKEY EV, Chotiyarnwong P, Harvey NC, Lorentzon M, et al
    Population screening for fracture risk in postmenopausal women - a logical step in reducing the osteoporotic fracture burden?
    Osteoporos Int. 2022 Jun 28. pii: 10.1007/s00198-022-06419.
    PubMed    


  55. ABDALBARY M, Sobh M, Elnagar S, Elhadedy MA, et al
    Management of osteoporosis in patients with chronic kidney disease.
    Osteoporos Int. 2022 Jun 24. pii: 10.1007/s00198-022-06462.
    PubMed     Abstract available


  56. BONLOKKE SE, Rand MS, Haddock B, Arup S, et al
    Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study.
    Osteoporos Int. 2022 Jun 21. pii: 10.1007/s00198-022-06457.
    PubMed     Abstract available


  57. DUONG LT, Clark S, Pickarski M, Giezek H, et al
    Effects of odanacatib on bone-turnover markers in osteoporotic postmenopausal women: a post hoc analysis of the LOFT study.
    Osteoporos Int. 2022 Jun 17. pii: 10.1007/s00198-022-06406.
    PubMed     Abstract available


  58. ZHANG F, Wang Z, Su H, Zhao H, et al
    Effect of a home-based resistance exercise program in elderly participants with osteoporosis: a randomized controlled trial.
    Osteoporos Int. 2022 Jun 15. pii: 10.1007/s00198-022-06456.
    PubMed     Abstract available


  59. TALEVSKI J, Sanders KM, Lal A, Watts JJ, et al
    A micro-costing analysis of post-fracture care pathways: results from the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS).
    Osteoporos Int. 2022 Jun 15. pii: 10.1007/s00198-022-06460.
    PubMed     Abstract available


  60. BAILEY S, Mhango G, Lin JJ
    The impact of bone mineral density screening on incident fractures and healthcare resource utilization among postmenopausal breast cancer survivors treated with aromatase inhibitors.
    Osteoporos Int. 2022 Jun 14. pii: 10.1007/s00198-022-06458.
    PubMed     Abstract available


  61. PASKINS Z, Babatunde O, Sturrock A, Toh LS, et al
    Supporting patients to get the best from their osteoporosis treatment: a rapid realist review of what works, for whom, and in what circumstance.
    Osteoporos Int. 2022 Jun 11. pii: 10.1007/s00198-022-06453.
    PubMed     Abstract available


  62. XIAO PL, Cui AY, Hsu CJ, Peng R, et al
    Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: a systematic review and meta-analysis.
    Osteoporos Int. 2022 Jun 10. pii: 10.1007/s00198-022-06454.
    PubMed     Abstract available


  63. ROSS BJ, Ross AJ, Lee OC, Waters TL, et al
    Osteoporosis management and secondary fragility fracture rates in patients with multiple sclerosis: a matched cohort study.
    Osteoporos Int. 2022 Jun 7. pii: 10.1007/s00198-022-06451.
    PubMed     Abstract available


  64. GOLD LS, Cody RF Jr, Tan WK, Marcum ZA, et al
    Osteoporosis identification among previously undiagnosed individuals with vertebral fractures.
    Osteoporos Int. 2022 Jun 3. pii: 10.1007/s00198-022-06450.
    PubMed     Abstract available


  65. ALOIA JF, Islam S
    Trabecular bone score in PODA, a Randomized Controlled Trial (RCT) in older African American Women.
    Osteoporos Int. 2022;33:1411-1412.
    PubMed    


  66. JACOB JJ, Paul TV
    Romosozumab and cardiovascular safety-should we learn lessons from pioglitazone?
    Osteoporos Int. 2022;33:1397-1399.
    PubMed    


  67. TOMINAGA A, Wada K, Okazaki K, Nishi H, et al
    Response to Letter. "Romosozumab and cardiovascular safety- should we learn lessons from Pioglitazone?."
    Osteoporos Int. 2022;33:1401-1402.
    PubMed    


  68. COSMAN F, Kendler DL, Langdahl BL, Leder BZ, et al
    Romosozumab and antiresorptive treatment: the importance of treatment sequence.
    Osteoporos Int. 2022;33:1243-1256.
    PubMed     Abstract available


    May 2022
  69. CHOO YW, Mohd Tahir NA, Mohamed Said MS, Li SC, et al
    Cost-effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in Malaysia.
    Osteoporos Int. 2022 May 31. pii: 10.1007/s00198-022-06444.
    PubMed     Abstract available


  70. VANDENPUT L, Johansson H, McCloskey EV, Liu E, et al
    Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan.
    Osteoporos Int. 2022 May 31. pii: 10.1007/s00198-022-06435.
    PubMed     Abstract available


  71. RIVERA-PAREDEZ B, Quezada-Sanchez AD, Robles-Rivera K, Hidalgo-Bravo A, et al
    Dietary inflammatory index and bone mineral density in Mexican population.
    Osteoporos Int. 2022 May 28. pii: 10.1007/s00198-022-06434.
    PubMed     Abstract available


  72. LEE K, Al Jumaily K, Lin M, Siminoski K, et al
    Dual-energy x-ray absorptiometry scanner mismatch in follow-up bone mineral density testing.
    Osteoporos Int. 2022 May 26. pii: 10.1007/s00198-022-06438.
    PubMed     Abstract available


  73. SAHOTA A, Barbary R, Cameron M, Stewart AM, et al
    Safety of zoledronate in older patients at high risk of fracture with reduced renal function.
    Osteoporos Int. 2022 May 23. pii: 10.1007/s00198-022-06427.
    PubMed    


  74. BELAYA Z, Melnichenko G, Golounina O, Tsoriev T, et al
    Three-year progress report of Bone Health TeleECHO Moscow: a strategy to improve the care of patients with osteoporosis and other metabolic skeletal diseases in underserved communities of Russia.
    Osteoporos Int. 2022 May 20. pii: 10.1007/s00198-022-06431.
    PubMed     Abstract available


  75. KONG XK, Zhao ZY, Zhang D, Xie R, et al
    Major osteoporosis fracture prediction in type 2 diabetes: a derivation and comparison study.
    Osteoporos Int. 2022 May 18. pii: 10.1007/s00198-022-06425.
    PubMed     Abstract available


  76. TSAKNAKIS K, Jackle K, Luders KA, Lorenz HM, et al
    Reduced bone mineral density in adolescents with Duchenne Muscular Dystrophy (DMD) and scoliosis.
    Osteoporos Int. 2022 May 18. pii: 10.1007/s00198-022-06416.
    PubMed     Abstract available


  77. ZHAO C, Liu X, Wang Y, Guo J, et al
    The effects of biomechanical factors on adjacent vertebral compression fractures after percutaneous kyphoplasty: a propensity score matching analysis.
    Osteoporos Int. 2022 May 18. pii: 10.1007/s00198-022-06428.
    PubMed     Abstract available


  78. KONSTANTELOS N, Rzepka AM, Burden AM, Cheung AM, et al
    Fracture definitions in observational osteoporosis drug effects studies that leverage healthcare administrative (claims) data: a scoping review.
    Osteoporos Int. 2022 May 17. pii: 10.1007/s00198-022-06395.
    PubMed     Abstract available


  79. BRUELL S, Nicholls KM, Hewitson TD, Talbot AS, et al
    Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease.
    Osteoporos Int. 2022 May 16. pii: 10.1007/s00198-022-06420.
    PubMed     Abstract available


  80. HAYDEN AC, Binkley N, Krueger D, Bernatz JT, et al
    Effect of degeneration on bone mineral density, trabecular bone score and CT Hounsfield unit measurements in a spine surgery patient population.
    Osteoporos Int. 2022 May 12. pii: 10.1007/s00198-022-06407.
    PubMed     Abstract available


  81. SHABANI F, Tsinaslanidis G, Thimmaiah R, Khatak M, et al
    Correction to: Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care.
    Osteoporos Int. 2022 May 3. pii: 10.1007/s00198-022-06323.
    PubMed    


    April 2022
  82. LEBOFF MS, Greenspan SL, Insogna KL, Lewiecki EM, et al
    The clinician's guide to prevention and treatment of osteoporosis.
    Osteoporos Int. 2022 Apr 28. pii: 10.1007/s00198-021-05900.
    PubMed     Abstract available


  83. CARBALLIDO-GAMIO J, Posadzy M, Wu PH, Kenny K, et al
    People living with HIV have low trabecular bone mineral density, high bone marrow adiposity, and poor trabecular bone microarchitecture at the proximal femur.
    Osteoporos Int. 2022 Apr 27. pii: 10.1007/s00198-022-06405.
    PubMed     Abstract available


  84. ZHANG X, Xu Y, Li F, Chen M, et al
    Associations between bone mineral density and subclinical peripheral arterial disease in elderly men with type 2 diabetes mellitus.
    Osteoporos Int. 2022 Apr 22. pii: 10.1007/s00198-022-06404.
    PubMed     Abstract available


  85. JOHANSSON L, Johansson H, Axelsson KF, Litsne H, et al
    Improved fracture risk prediction by adding VFA-identified vertebral fracture data to BMD by DXA and clinical risk factors used in FRAX.
    Osteoporos Int. 2022 Apr 22. pii: 10.1007/s00198-022-06387.
    PubMed     Abstract available


  86. ZENG X, Su Y, Tan A, Zou L, et al
    The association of coffee consumption with the risk of osteoporosis and fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2022 Apr 15. pii: 10.1007/s00198-022-06399.
    PubMed     Abstract available


  87. HILIGSMANN M, Li N, Cooper C, Reginster JY, et al
    Improving the reporting of economic evaluation in osteoporosis: the value of CHEERS 2022 statement.
    Osteoporos Int. 2022 Apr 12. pii: 10.1007/s00198-022-06400.
    PubMed    


  88. XU W, Wu W, Yang S, Chen T, et al
    Correction to: Risk of osteoporosis and fracture after hysterectomies without oophorectomies: a systematic review and pooled analysis.
    Osteoporos Int. 2022 Apr 6. pii: 10.1007/s00198-022-06397.
    PubMed    


  89. KIM D, Pirshahid AA, Li Y, Varghese T, et al
    Prevalence of osteoporosis in osteoarthritis: a systematic review and meta-analysis.
    Osteoporos Int. 2022 Apr 5. pii: 10.1007/s00198-022-06376.
    PubMed     Abstract available


  90. HARRIS RJ, Parimi N, Cawthon PM, Strotmeyer ES, et al
    Associations of components of sarcopenia with risk of fracture in the Osteoporotic Fractures in Men (MrOS) study.
    Osteoporos Int. 2022 Apr 5. pii: 10.1007/s00198-022-06390.
    PubMed     Abstract available


  91. DU EZ, Wang YXJ
    CT detects more osteoporotic endplate depressions than radiograph: a descriptive comparison of 76 vertebrae.
    Osteoporos Int. 2022 Apr 4. pii: 10.1007/s00198-022-06391.
    PubMed     Abstract available


  92. MINISOLA S, Cipriani C, Vigna E, Sonato C, et al
    COVID pandemic and denosumab adherence.
    Osteoporos Int. 2022;33:943-944.
    PubMed    


  93. EBINA K, Etani Y, Tsuboi H, Nagayama Y, et al
    Effects of prior osteoporosis treatment on the treatment response of romosozumab followed by denosumab in patients with postmenopausal osteoporosis.
    Osteoporos Int. 2022 Apr 1. pii: 10.1007/s00198-022-06386.
    PubMed     Abstract available



  94. IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference: Author Index.
    Osteoporos Int. 2022;33.
    PubMed    



  95. IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference : Poster Abstracts.
    Osteoporos Int. 2022;33.
    PubMed    



  96. IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference: Oral Communication Abstracts.
    Osteoporos Int. 2022;33.
    PubMed    



  97. IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference: Symposium Abstract.
    Osteoporos Int. 2022;33.
    PubMed    



  98. IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference: Speaker Abstracts.
    Osteoporos Int. 2022;33.
    PubMed    



  99. IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference.
    Osteoporos Int. 2022;33.
    PubMed    


    March 2022
  100. GONZALEZ-QUEVEDO D, Perez-Del-Rio V, Moriel-Garceso D, Fernandez-Arroyabe N, et al
    A 2-year follow-up of a novel Fracture Liaison Service: can we reduce the mortality in elderly hip fracture patients? A prospective cohort study.
    Osteoporos Int. 2022 Mar 31. pii: 10.1007/s00198-022-06298.
    PubMed     Abstract available


  101. LENTLE BC, Prior JC
    Osteoporotic vertebral fracture (OVF): diagnosis requires an informed observer.
    Osteoporos Int. 2022 Mar 30. pii: 10.1007/s00198-021-06287.
    PubMed    


  102. WANG YXJ
    Osteoporotic vertebral endplate and/or cortex fracture is not always radiographically detectable.
    Osteoporos Int. 2022 Mar 30. pii: 10.1007/s00198-021-06254.
    PubMed    


  103. XU WX, Wu W, Yang S, Chen T, et al
    Risk of osteoporosis and fracture after hysterectomies without oophorectomies: a systematic review and pooled analysis.
    Osteoporos Int. 2022 Mar 29. pii: 10.1007/s00198-022-06383.
    PubMed     Abstract available


  104. AKESSON KE, Ganda K, Deignan C, Oates MK, et al
    Post-fracture care programs for prevention of subsequent fragility fractures: a literature assessment of current trends.
    Osteoporos Int. 2022 Mar 24. pii: 10.1007/s00198-022-06358.
    PubMed     Abstract available


  105. SCHOEB M, Winter EM, Malgo F, Schipper IB, et al
    Bone material strength index as measured by in vivo impact microindentation is normal in subjects with high-energy trauma fractures.
    Osteoporos Int. 2022 Mar 21. pii: 10.1007/s00198-022-06368.
    PubMed     Abstract available


  106. KAST S, Shojaa M, Kohl M, von Stengel S, et al
    Effects of different exercise intensity on bone mineral density in adults: a comparative systematic review and meta-analysis.
    Osteoporos Int. 2022 Mar 18. pii: 10.1007/s00198-022-06329.
    PubMed     Abstract available


  107. JAVAID MK, Harvey NC, McCloskey EV, Kanis JA, et al
    Assessment and management of imminent fracture risk in the setting of the fracture liaison service.
    Osteoporos Int. 2022 Mar 14. pii: 10.1007/s00198-021-06284.
    PubMed    


  108. HA J, Baek KH
    Correction to: Response to letter, re. "Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data".
    Osteoporos Int. 2022 Mar 11. pii: 10.1007/s00198-022-06373.
    PubMed    


  109. TUCK SP, Datta HK
    Letter of response to Professor Dalgleish regarding our paper Re: Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a1 gene.
    Osteoporos Int. 2022 Mar 2. pii: 10.1007/s00198-022-06332.
    PubMed    


  110. DALGLEISH R
    Re: Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a1 gene.
    Osteoporos Int. 2022 Mar 2. pii: 10.1007/s00198-022-06334.
    PubMed    


    February 2022
  111. SANCHEZ-TRIGO H, Rittweger J, Sanudo B
    Effects of non-supervised exercise interventions on bone mineral density in adult women: a systematic review and metaanalysis.
    Osteoporos Int. 2022 Feb 26. pii: 10.1007/s00198-022-06357.
    PubMed     Abstract available


  112. OKUDA R, Osaki M, Saeki Y, Okano T, et al
    Effect of coordinator-based osteoporosis intervention on quality of life in patients with fragility fractures: a prospective randomized trial.
    Osteoporos Int. 2022 Feb 23. pii: 10.1007/s00198-021-06279.
    PubMed     Abstract available


  113. BASTOUNIS A, Langley T, Davis S, Paskins Z, et al
    Comparing medication adherence in patients receiving bisphosphonates for preventing fragility fractures: a comprehensive systematic review and network meta-analysis.
    Osteoporos Int. 2022 Feb 21. pii: 10.1007/s00198-022-06350.
    PubMed     Abstract available


  114. OTHMAN M, Menon VK
    The prevalence of Schmorl's nodes in osteoporotic vs normal patients: a Middle Eastern population study.
    Osteoporos Int. 2022 Feb 17. pii: 10.1007/s00198-022-06316.
    PubMed     Abstract available


  115. LESLIE WD, Moller S, Skjodt MK, Yan L, et al
    FREM predicts 10-year incident fracture risk independent of FRAX(R) probability: a registry-based cohort study.
    Osteoporos Int. 2022 Feb 17. pii: 10.1007/s00198-022-06349.
    PubMed     Abstract available


  116. JEONGHOON H, Ki-Hyun B
    Response to letter, re. "Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data".
    Osteoporos Int. 2022 Feb 17. pii: 10.1007/s00198-022-06336.
    PubMed    


  117. GEBRE AK, Prince RL, Schousboe JT, Kiel DP, et al
    Calcaneal quantitative ultrasound is associated with all-cause and cardiovascular disease mortality independent of hip bone mineral density.
    Osteoporos Int. 2022 Feb 11. pii: 10.1007/s00198-022-06317.
    PubMed     Abstract available


  118. KHALID S, Calderon-Larranaga S, Sami A, Hawley S, et al
    Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database.
    Osteoporos Int. 2022 Feb 9. pii: 10.1007/s00198-021-06262.
    PubMed     Abstract available


  119. FLEHR A, Kallgard J, Alven J, Lagerstrand K, et al
    Development of a novel method to measure bone marrow fat fraction in older women using high-resolution peripheral quantitative computed tomography.
    Osteoporos Int. 2022 Feb 3. pii: 10.1007/s00198-021-06224.
    PubMed     Abstract available


  120. GAGGIANO C, Bardelli M, Tarsia M, Gentileschi S, et al
    Neridronate for transient osteoporosis of the hip in a child.
    Osteoporos Int. 2022 Feb 1. pii: 10.1007/s00198-022-06324.
    PubMed     Abstract available


  121. ABDEL-HAMID MS, Elhossini RM, Otaify GA, Abdel-Ghafar SF, et al
    Osteoporosis-pseudoglioma syndrome in four new patients: identification of two novel LRP5 variants and insights on patients' management using bisphosphonates therapy.
    Osteoporos Int. 2022 Feb 1. pii: 10.1007/s00198-022-06313.
    PubMed     Abstract available


  122. CANOY D, Harvey NC, Prieto-Alhambra D, Cooper C, et al
    Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions.
    Osteoporos Int. 2022;33:315-326.
    PubMed     Abstract available


    January 2022
  123. GOSSIEL F, Ugur A, Peel NFA, Walsh JS, et al
    The clinical utility of TRACP-5b to monitor anti-resorptive treatments of osteoporosis.
    Osteoporos Int. 2022 Jan 31. pii: 10.1007/s00198-022-06311.
    PubMed     Abstract available


  124. ASAHI R, Nakamura Y, Kanai M, Watanabe K, et al
    Association with sagittal alignment and osteoporosis-related fractures in outpatient women with osteoporosis.
    Osteoporos Int. 2022 Jan 29. pii: 10.1007/s00198-021-06282.
    PubMed     Abstract available


  125. BEAUDART C, Boonen A, Li N, Bours S, et al
    Patient preferences for lifestyle behaviours in osteoporotic fracture prevention: a cross-European discrete choice experiment.
    Osteoporos Int. 2022 Jan 26. pii: 10.1007/s00198-022-06310.
    PubMed     Abstract available


  126. STARUP-LINDE J, Langdahl B, Vestergaard P, Harslof T, et al
    Incident peptic ulcers and concomitant treatment of direct oral anticoagulants and oral bisphosphonates-a real-world cohort study.
    Osteoporos Int. 2022 Jan 26. pii: 10.1007/s00198-022-06315.
    PubMed     Abstract available


  127. GUPTA A, Cha T, Schwab J, Fogel H, et al
    Response to Assessing impacts of gender on adverse postoperative outcomes in patients undergoing osteoporotic vertebral compression fracture surgery.
    Osteoporos Int. 2022 Jan 21. pii: 10.1007/s00198-021-06243.
    PubMed    


  128. HONG FX, Xue FS, Hu B, Tian T, et al
    Assessing impacts of gender on adverse postoperative outcomes in patients undergoing osteoporotic vertebral compression fracture surgery.
    Osteoporos Int. 2022 Jan 21. pii: 10.1007/s00198-021-05992.
    PubMed    


  129. WAN Y, Zeng F, Tan H, Lu Y, et al
    Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review.
    Osteoporos Int. 2022 Jan 21. pii: 10.1007/s00198-021-06268.
    PubMed     Abstract available


  130. TOMINAGA A, Wada K, Okazaki K, Nishi H, et al
    Effect of the duration of previous osteoporosis treatment on the effect of romosozumab treatment.
    Osteoporos Int. 2022 Jan 21. pii: 10.1007/s00198-021-06261.
    PubMed     Abstract available


  131. PINTO D, Alshahrani M, Chapurlat R, Chevalley T, et al
    The global approach to rehabilitation following an osteoporotic fragility fracture: A review of the rehabilitation working group of the International Osteoporosis Foundation (IOF) committee of scientific advisors.
    Osteoporos Int. 2022 Jan 20. pii: 10.1007/s00198-021-06240.
    PubMed     Abstract available


  132. SCHOUSBOE JT, Binkley N, Leslie WD
    Accurate estimation of vertebral fracture prevalence on lateral spine imaging requires use of validated ascertainment methods.
    Osteoporos Int. 2022 Jan 16. pii: 10.1007/s00198-021-06275.
    PubMed    


  133. LAI EC, Lin TC, Lange JL, Chen L, et al
    Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study.
    Osteoporos Int. 2022 Jan 15. pii: 10.1007/s00198-021-06291.
    PubMed     Abstract available


  134. PATEL R, Shen J, Nichols JF, Schousboe JT, et al
    Trabecular bone score and its association with Cobb angle kyphosis in older men: a cross-sectional study for the Osteoporotic Fractures in Men (MrOS) Study.
    Osteoporos Int. 2022 Jan 15. pii: 10.1007/s00198-021-06267.
    PubMed     Abstract available


  135. KIMMEL DB, Vennin S, Desyatova A, Turner JA, et al
    Bone architecture, bone material properties, and bone turnover in non-osteoporotic post-menopausal women with fragility fracture.
    Osteoporos Int. 2022 Jan 15. pii: 10.1007/s00198-022-06308.
    PubMed     Abstract available


  136. STROM RONNQUIST S, Viberg B, Kristensen MT, Palm H, et al
    Frailty and osteoporosis in patients with hip fractures under the age of 60-a prospective cohort of 218 individuals.
    Osteoporos Int. 2022 Jan 14. pii: 10.1007/s00198-021-06281.
    PubMed     Abstract available


  137. IIDA H, Sakai Y, Seki T, Watanabe T, et al
    Bisphosphonate treatment is associated with decreased mortality rates in patients after osteoporotic vertebral fracture.
    Osteoporos Int. 2022 Jan 13. pii: 10.1007/s00198-021-06264.
    PubMed     Abstract available


  138. IKI M, Fujimori K, Nakatoh S, Tamaki J, et al
    Guideline adherence by physicians for management of glucocorticoid-induced osteoporosis in Japan: a nationwide health insurance claims database study.
    Osteoporos Int. 2022 Jan 13. pii: 10.1007/s00198-021-06265.
    PubMed     Abstract available


  139. LIANG YS, Yeh KC, Pan SL
    Osteoporosis and the long-term risk of peripheral artery disease: a population-based longitudinal follow-up study in Taiwan.
    Osteoporos Int. 2022 Jan 12. pii: 10.1007/s00198-022-06305.
    PubMed     Abstract available


  140. BERNARDES M, Monteiro R, Martins MJ
    Mineral-rich water consumption as a non-pharmacological intervention for early menopausal bone mineral density preservation and reduction of long-term fracture risk: comment on Billington et al. Osteoporos Int. 2021;32(7):1313-20.
    Osteoporos Int. 2022 Jan 12. pii: 10.1007/s00198-021-06272.
    PubMed    


  141. SHABANI F, Tsinaslanidis G, Thimmaiah R, Khatak M, et al
    Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care.
    Osteoporos Int. 2022 Jan 8. pii: 10.1007/s00198-021-06249.
    PubMed     Abstract available


  142. CLAUSEN A, Moller S, Skjodt MK, Bech BH, et al
    Evaluating the performance of the Charlson Comorbidity Index (CCI) in fracture risk prediction and developing a new Charlson Fracture Index (CFI): a register-based cohort study.
    Osteoporos Int. 2022 Jan 6. pii: 10.1007/s00198-021-06293.
    PubMed     Abstract available


  143. SAAD RK, Ghezzawi M, Habli D, Alami RS, et al
    Fracture risk following bariatric surgery: a systematic review and meta-analysis.
    Osteoporos Int. 2022 Jan 5. pii: 10.1007/s00198-021-06206.
    PubMed     Abstract available


  144. BERMAN NK, Honig S, Cronstein BN, Pillinger MH, et al
    The effects of caffeine on bone mineral density and fracture risk.
    Osteoporos Int. 2022 Jan 4. pii: 10.1007/s00198-021-05972.
    PubMed     Abstract available


  145. DOCKERY F, Glynn A, Franks K, Carey JJ, et al
    Fracture liaison services in Ireland-how do we compare to international standards?
    Osteoporos Int. 2022 Jan 4. pii: 10.1007/s00198-021-06251.
    PubMed     Abstract available


  146. PARK SY, Kim J, Chung HY
    Denosumab-induced hypocalcemia in a patient with hyperthyroidism: a case report.
    Osteoporos Int. 2022;33:305-308.
    PubMed     Abstract available


    December 2021
  147. FAN Y, Ni S, Zhang H
    Association between Healthy Eating Index-2015 total and component food scores with osteoporosis in middle-aged and older Americans: a cross-sectional study with U.S. National Health and Nutrition Examination Survey.
    Osteoporos Int. 2021 Dec 2. pii: 10.1007/s00198-021-06247.
    PubMed     Abstract available


  148. NASSAR K, Janani S
    Diffuse adverse cutaneous reactions induced by zoledronic acid administration: a case report : Eruptions cutanees diffuses induites par l'administration de l'acide zoledronique.
    Osteoporos Int. 2021;32:2583-2586.
    PubMed     Abstract available


  149. BOCKER W, Doobaree IU, Khachatryan A, Dornstauder E, et al
    Correction to: Fractures in untreated patients with osteoporosis in Germany: an InGef healthcare insurance database analysis.
    Osteoporos Int. 2021 Dec 1. pii: 10.1007/s00198-021-06244.
    PubMed    


  150. CURTIN L, Conway MC, Kilbane MT, McKenna MJ, et al
    No effect of maternal calcium intake and bone resorption during pregnancy on offspring bone mineral density at age 5 years.
    Osteoporos Int. 2021 Dec 1. pii: 10.1007/s00198-021-06250.
    PubMed     Abstract available



  151. World Congress on Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Author Index.
    Osteoporos Int. 2021;32.
    PubMed    



  152. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Poster Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  153. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Satellite Sponsored Symposium Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  154. World Congress on Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Non-Sponsored Symposia Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  155. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Committee of Scientific Advisory Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  156. World congress on osteoporosis, osteoarthritis and musculoskeletal diseases (WCO-IOF-ESCEO 2021): Committee of National Societies Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  157. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Meet-The-Experts Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  158. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ISGE-ESCEO Symposium Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  159. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ROS-IOF-ESCEO Symposium Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  160. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): SICOT-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  161. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): EUGMS-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  162. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ESPRM-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  163. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ESCEO-WHO CC Symposium Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  164. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  165. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ESCEO Symposium Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  166. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Oral Communication Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  167. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Plenary Lecture Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  168. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Educational Lectures Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  169. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Special Lecture Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  170. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021).
    Osteoporos Int. 2021;32.
    PubMed    


    November 2021
  171. AGARWAL A, Leslie WD, Nguyen TV, Morin SN, et al
    Predictive performance of the Garvan Fracture Risk Calculator: a registry-based cohort study.
    Osteoporos Int. 2021 Nov 28. pii: 10.1007/s00198-021-06252.
    PubMed     Abstract available


  172. AGARWAL G, Milan C, Mohsin Z, Mahoney S, et al
    Multiple myeloma screening within a fracture liaison service (FLS).
    Osteoporos Int. 2021 Nov 26. pii: 10.1007/s00198-021-06233.
    PubMed     Abstract available


  173. HORII C, Iidaka T, Muraki S, Oka H, et al
    The cumulative incidence of and risk factors for morphometric severe vertebral fractures in Japanese men and women: the ROAD study third and fourth surveys.
    Osteoporos Int. 2021 Nov 19. pii: 10.1007/s00198-021-06143.
    PubMed     Abstract available


  174. KADRI A, Binkley N, Hernando D, Anderson PA, et al
    Opportunistic Use of Lumbar Magnetic Resonance Imaging for Osteoporosis Screening.
    Osteoporos Int. 2021 Nov 13. pii: 10.1007/s00198-021-06129.
    PubMed     Abstract available


  175. RUBAEK M, Hitz MF, Holmberg T, Schonwandt BMT, et al
    Effectiveness of patient education for patients with osteoporosis: a systematic review.
    Osteoporos Int. 2021 Nov 12. pii: 10.1007/s00198-021-06226.
    PubMed     Abstract available


  176. LIU Z, Zhang X, Liu H, Wang D, et al
    A nomogram for short-term recurrent pain after percutaneous vertebroplasty for osteoporotic vertebral compression fractures.
    Osteoporos Int. 2021 Nov 11. pii: 10.1007/s00198-021-06232.
    PubMed     Abstract available


  177. DEMINGER A, Klingberg E, Lorentzon M, Hedberg M, et al
    Correction to: Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT.
    Osteoporos Int. 2021 Nov 2. pii: 10.1007/s00198-021-06156.
    PubMed    


    October 2021
  178. SAITO M, Moore-Lotridge SN, Uppuganti S, Egawa S, et al
    Determining the pharmacologic window of bisphosphonates that mitigates severe injury-induced osteoporosis and muscle calcification, while preserving fracture repair.
    Osteoporos Int. 2021 Oct 31. pii: 10.1007/s00198-021-06208.
    PubMed     Abstract available


  179. THARABENJASIN P, Pabalan N, Jarjanazi H, Jinawath N, et al
    Associations of osteoprotegerin (OPG) TNFRSF11B gene polymorphisms with risk of fractures in older adult populations: meta-analysis of genetic and genome-wide association studies.
    Osteoporos Int. 2021 Oct 30. pii: 10.1007/s00198-021-06161.
    PubMed     Abstract available


  180. ADAMS AL, Ryan DS, Li BH, Williams SA, et al
    Outcomes post fragility fracture among members of an integrated healthcare organization.
    Osteoporos Int. 2021 Oct 23. pii: 10.1007/s00198-021-06205.
    PubMed     Abstract available


  181. PRIOR JC, Oei EHG, Brown JP, Oei L, et al
    Where's the break? Critique of radiographic vertebral fracture diagnostic methods.
    Osteoporos Int. 2021 Oct 21. pii: 10.1007/s00198-021-06207.
    PubMed    


  182. CHEN T, Jiang R, Jiang L
    Comment on "Influence of glycemic control and hypoglycemia on the risk of fracture in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies".
    Osteoporos Int. 2021 Oct 21. pii: 10.1007/s00198-021-06217.
    PubMed    


  183. ASPDEN RM
    RE: Advanced 2D image processing technique to predict hip fracture risk in an older population based on single DXA scans : F. Jazinizadeh, J.D. Adachi & C.E. Quenneville. Osteoporosis International volume 31, pages 1925-1933 (2020).
    Osteoporos Int. 2021 Oct 19. pii: 10.1007/s00198-021-06096.
    PubMed    


  184. GOETZ TG, Nair N, Shiau S, Recker RR, et al
    In premenopausal women with idiopathic osteoporosis, lower bone formation rate is associated with higher body fat and higher IGF-1.
    Osteoporos Int. 2021 Oct 19. pii: 10.1007/s00198-021-06196.
    PubMed     Abstract available


  185. JAZINIZADEH F, Adachi J, Quenneville C
    Response to Letter from Prof Aspen, re. "Advanced 2D image processing technique to predict hip fracture risk in an older population based on single DXA scans".
    Osteoporos Int. 2021 Oct 19. pii: 10.1007/s00198-021-06192.
    PubMed    


  186. SCHINI M, Peel N, Toronjo-Urquiza L, Thomas E, et al
    Evaluation of estimated glomerular function (eGFR) versus creatinine clearance (CrCl) to predict acute kidney injury when using zoledronate for the treatment of osteoporosis.
    Osteoporos Int. 2021 Oct 15. pii: 10.1007/s00198-021-06160.
    PubMed     Abstract available


  187. LOFFLER MT, Kallweit M, Niederreiter E, Baum T, et al
    Epidemiology and reporting of osteoporotic vertebral fractures in patients with long-term hospital records based on routine clinical CT imaging.
    Osteoporos Int. 2021 Oct 14. pii: 10.1007/s00198-021-06169.
    PubMed     Abstract available


  188. YAZDANPANAH Z, Beigrezaei S, Mohseni-Takalloo S, Soltani S, et al
    Does exercise affect bone mineral density and content when added to a calorie-restricted diet? A systematic review and meta-analysis of controlled clinical trials.
    Osteoporos Int. 2021 Oct 13. pii: 10.1007/s00198-021-06187.
    PubMed     Abstract available


  189. CHALITSIOS CV, Shaw DE, McKeever TM
    Risk of subtrochanteric and femoral shaft fractures due to bisphosphonate therapy in asthma: a population-based nested case-control study.
    Osteoporos Int. 2021 Oct 11. pii: 10.1007/s00198-021-06197.
    PubMed     Abstract available


  190. KUO DP, Chiu YW, Chen PT, Tsai YJ, et al
    Associations between body composition and vertebral fracture risk in postmenopausal women.
    Osteoporos Int. 2021 Oct 9. pii: 10.1007/s00198-021-06178.
    PubMed     Abstract available


  191. MUSCHITZ C, Hummer M, Grillari J, Hlava A, et al
    Epidemiology and economic burden of fragility fractures in Austria.
    Osteoporos Int. 2021 Oct 8. pii: 10.1007/s00198-021-06152.
    PubMed     Abstract available


  192. SAFIPOUR Z, van der Zanden R, van den Bergh J, Janssen P, et al
    The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis.
    Osteoporos Int. 2021 Oct 3. pii: 10.1007/s00198-021-06101.
    PubMed     Abstract available


  193. MOLLER S, Skjodt MK, Yan L, Abrahamsen B, et al
    Prediction of imminent fracture risk in Canadian women and men aged 45 years or older: external validation of the Fracture Risk Evaluation Model (FREM).
    Osteoporos Int. 2021 Oct 1. pii: 10.1007/s00198-021-06165.
    PubMed     Abstract available


    September 2021
  194. LESLIE WD, Yan L, Lix LM, Morin SN, et al
    Time dependency in early major osteoporotic and hip re-fractures in women and men aged 50 years and older: a population-based observational study.
    Osteoporos Int. 2021 Sep 25. pii: 10.1007/s00198-021-06166.
    PubMed     Abstract available


  195. BEAUDART C, Hiligsmann M, Li N, Lewiecki EM, et al
    Effective communication regarding risk of fracture for individuals at risk of fragility fracture: a scoping review.
    Osteoporos Int. 2021 Sep 24. pii: 10.1007/s00198-021-06151.
    PubMed     Abstract available


  196. GASSERT FT, Kufner A, Gassert FG, Leonhardt Y, et al
    MR-based proton density fat fraction (PDFF) of the vertebral bone marrow differentiates between patients with and without osteoporotic vertebral fractures.
    Osteoporos Int. 2021 Sep 18. pii: 10.1007/s00198-021-06147.
    PubMed     Abstract available


  197. WALTMAN N, Kupzyk KA, Flores LE, Mack LR, et al
    Bone-loading exercises versus risedronate for the prevention of osteoporosis in postmenopausal women with low bone mass: a randomized controlled trial.
    Osteoporos Int. 2021 Sep 14. pii: 10.1007/s00198-021-06083.
    PubMed     Abstract available


  198. GONG Z, Da W, Tian Y, Zhao R, et al
    Exogenous melatonin prevents type 1 diabetes mellitus-induced bone loss, probably by inhibiting senescence.
    Osteoporos Int. 2021 Sep 14. pii: 10.1007/s00198-021-06061.
    PubMed     Abstract available


  199. NAYAK S, Greenspan SL
    Cost-effectiveness of 3 versus 6 years of zoledronic acid treatment before bisphosphonate holiday for women with osteoporosis.
    Osteoporos Int. 2021 Sep 13. pii: 10.1007/s00198-021-06010.
    PubMed     Abstract available


  200. COLON-EMERIC CS, Lee RH
    Bisphosphonate holidays: using cost-effectiveness analysis for the "yes, but" questions.
    Osteoporos Int. 2021 Sep 13. pii: 10.1007/s00198-021-06064.
    PubMed    


  201. BLAKER K, Wijewardene A, White E, Stokes G, et al
    Electronic search programs are effective in identifying patients with minimal trauma fractures.
    Osteoporos Int. 2021 Sep 12. pii: 10.1007/s00198-021-06105.
    PubMed     Abstract available


  202. LIU J, Gong T, Xu X, Fox KM, et al
    Heavy clinical and economic burden of osteoporotic fracture among elderly female Medicare beneficiaries.
    Osteoporos Int. 2021 Sep 10. pii: 10.1007/s00198-021-06084.
    PubMed     Abstract available


  203. LARSSON BAM, Johansson L, Mellstrom D, Johansson H, et al
    One leg standing time predicts fracture risk in older women independent of clinical risk factors and BMD.
    Osteoporos Int. 2021 Sep 8. pii: 10.1007/s00198-021-06039.
    PubMed     Abstract available


  204. THOMASIUS F, Palacios S, Alam A, Boolell M, et al
    Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis.
    Osteoporos Int. 2021 Sep 6. pii: 10.1007/s00198-021-06108.
    PubMed     Abstract available


  205. BLAND VL, Klimentidis YC, Bea JW, Roe DJ, et al
    Cross-sectional associations between adipose tissue depots and areal bone mineral density in the UK Biobank imaging study.
    Osteoporos Int. 2021 Sep 6. pii: 10.1007/s00198-021-06140.
    PubMed     Abstract available


  206. NIZNIK JD, Aspinall SL, Hanson LC, Gilliam MA, et al
    Patterns of oral bisphosphonate deprescribing in older nursing home residents with dementia.
    Osteoporos Int. 2021 Sep 4. pii: 10.1007/s00198-021-06141.
    PubMed     Abstract available


  207. PARK JH, Cho S, Kim SJ, Jeong TD, et al
    Serum biomarkers for bisphosphonate-related osteonecrosis of the jaw: a prospective clinical study.
    Osteoporos Int. 2021 Sep 2. pii: 10.1007/s00198-021-06137.
    PubMed     Abstract available


    August 2021
  208. VARENNA M, Crotti C, Bonati MT, Zucchi F, et al
    A novel mutation in collagen gene COL1A2 associated with transient regional osteoporosis.
    Osteoporos Int. 2021 Aug 31. pii: 10.1007/s00198-021-06135.
    PubMed     Abstract available


  209. HAGINO H, Sugimoto T, Tanaka S, Sasaki K, et al
    Correction to: A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese osteoporosis intervention Trial-05.
    Osteoporos Int. 2021 Aug 27. pii: 10.1007/s00198-021-06066.
    PubMed    


  210. SU S, He N, Men P, Song C, et al
    Correction to: The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2021 Aug 27. pii: 10.1007/s00198-021-06053.
    PubMed    


  211. SINGH S, Dutta S, Khasbage S, Kumar T, et al
    A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis.
    Osteoporos Int. 2021 Aug 25. pii: 10.1007/s00198-021-06095.
    PubMed     Abstract available


  212. BOSCHITSCH E, Naegele O, Klinger A, Brix-Samoylenko H, et al
    Long-term persistence with denosumab: real-world data from the Austrian Osteoporosis Clinic (AOC). A retrospective data analysis.
    Osteoporos Int. 2021 Aug 25. pii: 10.1007/s00198-021-06102.
    PubMed     Abstract available


  213. CHANDRAN M, Hao Y, Kwee AK, Cheen MHH, et al
    Adherence to dosing schedule of denosumab therapy for osteoporosis during COVID-19 lockdown: an electronic medical record and pharmacy claims database study from Asia.
    Osteoporos Int. 2021 Aug 21. pii: 10.1007/s00198-021-06085.
    PubMed     Abstract available


  214. SEAMAN AT, Steffen MJA, Van Tiem JM, Wardyn S, et al
    Cultivating across "pockets of excellence": challenges to sustaining efforts to improve osteoporosis care.
    Osteoporos Int. 2021 Aug 19. pii: 10.1007/s00198-021-06098.
    PubMed     Abstract available


  215. VENDRAMI C, Marques-Vidal P, Gonzalez Rodriguez E, Hans D, et al
    Thyroid-stimulating hormone is associated with trabecular bone score and 5-year incident fracture risk in euthyroid postmenopausal women: the OsteoLaus cohort.
    Osteoporos Int. 2021 Aug 19. pii: 10.1007/s00198-021-06081.
    PubMed     Abstract available


  216. ATMACA A, Demirci I, Haymana C, Tasci I, et al
    No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study.
    Osteoporos Int. 2021 Aug 17. pii: 10.1007/s00198-021-06067.
    PubMed     Abstract available


  217. KHALID S, Reyes C, Ernst M, Delmestri A, et al
    One- and 2-year incidence of osteoporotic fracture: a multi-cohort observational study using routinely collected real-world data.
    Osteoporos Int. 2021 Aug 15. pii: 10.1007/s00198-021-06077.
    PubMed     Abstract available


  218. ZHANG Y, Tian Z, Ye S, Mu Q, et al
    Changes in bone mineral density in Down syndrome individuals: a systematic review and meta-analysis.
    Osteoporos Int. 2021 Aug 12. pii: 10.1007/s00198-021-06070.
    PubMed     Abstract available


  219. BAJPAI RC
    Letter to the Editor about the article "C-reactive protein and fracture risk: an updated systematic review and meta-analysis of cohort studies through the use of both frequentist and Bayesian approaches".
    Osteoporos Int. 2021 Aug 12. pii: 10.1007/s00198-020-05750.
    PubMed    


  220. SCHEMITSCH E, Adachi JD, Brown JP, Tarride JE, et al
    Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients.
    Osteoporos Int. 2021 Aug 11. pii: 10.1007/s00198-021-06080.
    PubMed     Abstract available


  221. SOLLING AS, Harslof T, Bruun NH, Langdahl B, et al
    The predictive value of bone turnover markers during discontinuation of alendronate: the PROSA study.
    Osteoporos Int. 2021;32:1557-1566.
    PubMed     Abstract available


    July 2021
  222. HA J, Jeong C, Han KD, Lim Y, et al
    Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data.
    Osteoporos Int. 2021 Jul 31. pii: 10.1007/s00198-021-06032.
    PubMed     Abstract available


  223. BOCKER W, Doobare IU, Khachatryan A, Dornstauder E, et al
    Fractures in untreated patients with osteoporosis in Germany: an InGef healthcare insurance database analysis.
    Osteoporos Int. 2021 Jul 15. pii: 10.1007/s00198-021-06051.
    PubMed     Abstract available


  224. ADAMI G, Cattani G, Rossini M, Viapiana O, et al
    Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study.
    Osteoporos Int. 2021 Jul 15. pii: 10.1007/s00198-021-06060.
    PubMed     Abstract available


  225. IBRAHIMAGIC OC, Vujadinovic A, Ercegovic Z, Kunic S, et al
    Retraction Note to: Comment on an article: "Osteoporosis in the age of COVID-19 patients".
    Osteoporos Int. 2021 Jul 14. pii: 10.1007/s00198-021-06031.
    PubMed    


  226. DEMINGER A, Klingberg E, Lorentzon M, Hedberg M, et al
    Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT.
    Osteoporos Int. 2021 Jul 14. pii: 10.1007/s00198-021-06049.
    PubMed     Abstract available


  227. TALEVSKI J, Sanders KM, Watts JJ, Nicholson GC, et al
    Sex differences in recovery of quality of life 12 months post-fracture in community-dwelling older adults: analyses of the Australian arm of the International Costs and Utilities Related to Osteoporotic Fractures Study (AusICUROS).
    Osteoporos Int. 2021 Jul 8. pii: 10.1007/s00198-021-06058.
    PubMed     Abstract available


  228. HAMED K, Roaldsen KS, Halvarsson A
    "Fear of falling serves as protection and signifies potential danger": a qualitative study to conceptualise the phrase "fear of falling" in women with osteoporosis.
    Osteoporos Int. 2021 Jul 7. pii: 10.1007/s00198-021-06047.
    PubMed     Abstract available


  229. SALE JEM, Yang A, Elliot-Gibson V, Jain R, et al
    Patients 80 + have similar medication initiation rates to those aged 50-79 in Ontario FLS.
    Osteoporos Int. 2021;32:1405-1411.
    PubMed     Abstract available


    June 2021
  230. MORIN SN, Yan L, Lix LM, Leslie WD, et al
    Long-term risk of subsequent major osteoporotic fracture and hip fracture in men and women: a population-based observational study with a 25-year follow-up.
    Osteoporos Int. 2021 Jun 24. pii: 10.1007/s00198-021-06028.
    PubMed     Abstract available


  231. ZHU M, Yin P, Hu F, Jiang J, et al
    Integrating genome-wide association and transcriptome prediction model identifies novel target genes for osteoporosis.
    Osteoporos Int. 2021 Jun 17. pii: 10.1007/s00198-021-06024.
    PubMed     Abstract available


  232. EVENEPOEL P, Cunningham J, Ferrari S, Haarhaus M, et al
    Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism.
    Osteoporos Int. 2021 Jun 15. pii: 10.1007/s00198-021-05975.
    PubMed     Abstract available


  233. SINGER AJ, Liu J, Yan H, Stad RK, et al
    Treatment patterns and long-term persistence with osteoporosis therapies in women with Medicare fee-for-service (FFS) coverage.
    Osteoporos Int. 2021 Jun 7. pii: 10.1007/s00198-021-05951.
    PubMed     Abstract available


    May 2021
  234. CHANDRAN M, Mitchell PJ, Amphansap T, Bhadada SK, et al
    Publisher Correction to: Development of the Asia Pacific Consortium on Osteoporosis (APCO) framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region.
    Osteoporos Int. 2021 May 27. pii: 10.1007/s00198-021-05953.
    PubMed    


  235. STUMPF U, Kraus M, Hadji P
    Influence of denosumab on bone mineral density in a severe case of pregnancy-associated osteoporosis.
    Osteoporos Int. 2021 May 26. pii: 10.1007/s00198-021-06008.
    PubMed     Abstract available


  236. IKI M, Winzenrieth R, Tamaki J, Sato Y, et al
    Predictive ability of novel volumetric and geometric indices derived from dual-energy X-ray absorptiometric images of the proximal femur for hip fracture compared with conventional areal bone mineral density: the Japanese Population-based Osteoporosis
    Osteoporos Int. 2021 May 26. pii: 10.1007/s00198-021-06013.
    PubMed     Abstract available


  237. PAL R, Bhadada SK, Mukherjee S, Banerjee M, et al
    Fracture risk in hypoparathyroidism: a systematic review and meta-analysis.
    Osteoporos Int. 2021 May 22. pii: 10.1007/s00198-021-05966.
    PubMed     Abstract available


  238. VAN DEN BERGH JP, Szulc P, Cheung AM, Bouxsein M, et al
    The clinical application of high-resolution peripheral computed tomography (HR-pQCT) in adults: state of the art and future directions.
    Osteoporos Int. 2021 May 22. pii: 10.1007/s00198-021-05999.
    PubMed     Abstract available


  239. CHEVALLEY T, Brandi ML, Cavalier E, Harvey NC, et al
    How can the orthopedic surgeon ensure optimal vitamin D status in patients operated for an osteoporotic fracture?
    Osteoporos Int. 2021 May 20. pii: 10.1007/s00198-021-05957.
    PubMed     Abstract available


  240. SVENSSON J, Ohlsson C, Karlsson MK, Lorentzon M, et al
    Subclinical hyperthyroidism is associated with increased risk of vertebral fractures in older men.
    Osteoporos Int. 2021 May 19. pii: 10.1007/s00198-021-05964.
    PubMed     Abstract available


  241. HAGINO H, Sugimoto T, Tanaka S, Sone T, et al
    A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05.
    Osteoporos Int. 2021 May 17. pii: 10.1007/s00198-021-05996.
    PubMed     Abstract available


  242. CARDOZO B, Karatza E, Karalis V
    Osteoporosis treatment with risedronate: a population pharmacokinetic model for the description of its absorption and low plasma levels.
    Osteoporos Int. 2021 May 17. pii: 10.1007/s00198-021-05944.
    PubMed     Abstract available


  243. ANASTASILAKIS AD, Makras P, Doulgeraki A, Polyzos SA, et al
    Denosumab for the treatment of primary pediatric osteoporosis.
    Osteoporos Int. 2021 May 13. pii: 10.1007/s00198-021-06002.
    PubMed     Abstract available


  244. CHANG CB, Yang RS, Chang LY, Peng JK, et al
    One-year outcomes of an osteoporosis liaison services program initiated within a healthcare system.
    Osteoporos Int. 2021 May 6. pii: 10.1007/s00198-021-05859.
    PubMed     Abstract available


  245. LIU JJ, Fu SB, Jiang J, Tang XL, et al
    Association between outdoor particulate air pollution and the risk of osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2021 May 6. pii: 10.1007/s00198-021-05961.
    PubMed     Abstract available


  246. CASELLA M, Becciolini A, Di Donato E, Basaglia M, et al
    Internal medicine inpatients' prevalence of misdiagnosed severe osteoporosis.
    Osteoporos Int. 2021 May 5. pii: 10.1007/s00198-021-05976.
    PubMed     Abstract available


  247. JUNG YW, Hong N, Kim CO, Kim HC, et al
    The diagnostic value of phase angle, an integrative bioelectrical marker, for identifying individuals with dysmobility syndrome: the Korean Urban-Rural Elderly study.
    Osteoporos Int. 2021;32:939-949.
    PubMed     Abstract available


    April 2021
  248. SKIBICKI HE, Ponzio DY, Brustein JA, Post ZD, et al
    A cautionary case: osteoporotic femur fracture after robotic-assisted total knee arthroplasty.
    Osteoporos Int. 2021 Apr 30. pii: 10.1007/s00198-021-05977.
    PubMed     Abstract available


  249. YAMAMOTO Y, Chiba T, Dohmae S, Higashi K, et al
    Osteoporosis medication after fracture in older adults: an administrative data analysis.
    Osteoporos Int. 2021 Apr 29. pii: 10.1007/s00198-021-05973.
    PubMed    


  250. GU KD, Ettinger B, Grimsrud CD, Lo JC, et al
    Progression of atypical femur stress fracture after discontinuation of bisphosphonate therapy.
    Osteoporos Int. 2021 Apr 29. pii: 10.1007/s00198-021-05948.
    PubMed     Abstract available


  251. LYLES KW, Bauer DC, Colon-Emeric CS, Pieper CF, et al
    Zoledronic acid reduces the rate of clinical fractures after surgical repair of a hip fracture regardless of the Pretreatment bone mineral density.
    Osteoporos Int. 2021 Apr 27. pii: 10.1007/s00198-021-05923.
    PubMed     Abstract available


  252. KIM JT, Cha YH, Jeong S, Yoo JI, et al
    Subtrochanteric atypical femoral fracture induced solely by glucocorticoid without bisphosphonate treatment: a case report.
    Osteoporos Int. 2021 Apr 24. pii: 10.1007/s00198-021-05971.
    PubMed     Abstract available


  253. LIU ZM, Huang Q, Li SY, Liu YP, et al
    A 1:1 matched case-control study on dietary protein intakes and hip fracture risk in Chinese elderly men and women.
    Osteoporos Int. 2021 Apr 22. pii: 10.1007/s00198-021-05960.
    PubMed     Abstract available


  254. TENG Z, Zhu Y, Teng Y, Long Q, et al
    The analysis of osteosarcopenia as a risk factor for fractures, mortality, and falls.
    Osteoporos Int. 2021 Apr 20. pii: 10.1007/s00198-021-05963.
    PubMed     Abstract available


  255. HAUGER AV, Holvik K, Bergland A, Stahle A, et al
    Physical capability, physical activity, and their association with femoral bone mineral density in adults aged 40 years and older: The Tromso study 2015-2016.
    Osteoporos Int. 2021 Apr 16. pii: 10.1007/s00198-021-05949.
    PubMed     Abstract available


  256. HIDAYAT K, Fang QL, Shi BM, Qin LQ, et al
    Influence of glycemic control and hypoglycemia on the risk of fracture in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2021 Apr 16. pii: 10.1007/s00198-021-05934.
    PubMed     Abstract available


  257. SI L, Eisman JA, Winzenberg T, Sanders KM, et al
    Development and validation of the risk engine for an Australian Health Economics Model of Osteoporosis.
    Osteoporos Int. 2021 Apr 15. pii: 10.1007/s00198-021-05955.
    PubMed     Abstract available


  258. BARAKE M, El Eid R, Ajjour S, Chakhtoura M, et al
    Osteoporotic hip and vertebral fractures in the Arab region: a systematic review.
    Osteoporos Int. 2021 Apr 7. pii: 10.1007/s00198-021-05937.
    PubMed     Abstract available


  259. DUSSAULT PM, McCarthy D, Davis SA, Thakore-James M, et al
    High prevalence of vertebral fractures in seizure patients with normal bone density receiving chronic anti-epileptic drugs.
    Osteoporos Int. 2021 Apr 6. pii: 10.1007/s00198-021-05926.
    PubMed     Abstract available


  260. PLUSKIEWICZ W, Adamczyk P, Drozdzowska B
    Height loss in postmenopausal women-do we need more for fracture risk assessment? Results from the GO Study.
    Osteoporos Int. 2021 Apr 5. pii: 10.1007/s00198-021-05941.
    PubMed     Abstract available


  261. KANIS JA, Johansson H, Harvey NC, Lorentzon M, et al
    An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines : A report for the National Osteoporosis Guideline Group (NOGG).
    Osteoporos Int. 2021 Apr 4. pii: 10.1007/s00198-021-05942.
    PubMed     Abstract available


  262. DATTA HK, Vila J, Tuck SP
    Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a1 gene.
    Osteoporos Int. 2021 Apr 2. pii: 10.1007/s00198-021-05933.
    PubMed     Abstract available


  263. CHEN FP, Fu TS, Lin YC, Lin YJ, et al
    Addition of dexamethasone to manage acute phase responses following initial zoledronic acid infusion.
    Osteoporos Int. 2021;32:663-670.
    PubMed     Abstract available


    March 2021
  264. HAGINO H, Tanaka K, Silverman S, McClung M, et al
    Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan.
    Osteoporos Int. 2021 Mar 27. pii: 10.1007/s00198-021-05927.
    PubMed     Abstract available


  265. TOMINAGA A, Wada K, Okazaki K, Nishi H, et al
    Early clinical effects, safety, and predictors of the effects of romosozumab treatment in osteoporosis patients: one-year study.
    Osteoporos Int. 2021 Mar 26. pii: 10.1007/s00198-021-05925.
    PubMed     Abstract available


  266. SKJODT MK, Ernst MT, Khalid S, Libanati C, et al
    The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications.
    Osteoporos Int. 2021 Mar 15. pii: 10.1007/s00198-021-05890.
    PubMed     Abstract available


  267. FUGGLE NR, Singer A, Gill C, Patel A, et al
    Correction to: How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey.
    Osteoporos Int. 2021 Mar 9. pii: 10.1007/s00198-021-05905.
    PubMed    


  268. GIRGIS CM, Clifton-Bligh RJ
    Reply to Comment on "Osteoporosis in the Age of COVID-19".
    Osteoporos Int. 2021 Mar 4. pii: 10.1007/s00198-021-05901.
    PubMed    


  269. BARTOSCH P, Malmgren L, Kristensson J, McGuigan FE, et al
    In community-dwelling women frailty is associated with imminent risk of osteoporotic fractures.
    Osteoporos Int. 2021 Mar 4. pii: 10.1007/s00198-021-05886.
    PubMed     Abstract available


  270. BARZILAY JI, Buzkova P, Djousse L, Ix J, et al
    Serum non-esterified fatty acid levels and hip fracture risk: The Cardiovascular Health Study.
    Osteoporos Int. 2021 Mar 2. pii: 10.1007/s00198-021-05897.
    PubMed     Abstract available


  271. WINZENRIETH R, Ominsky MS, Wang Y, Humbert L, et al
    Differential effects of abaloparatide and teriparatide on hip cortical volumetric BMD by DXA-based 3D modeling.
    Osteoporos Int. 2021;32:575-583.
    PubMed     Abstract available


  272. ZULLO AR, Lee Y, Lary C, Daiello LA, et al
    Comparative effectiveness of denosumab, teriparatide, and zoledronic acid among frail older adults: a retrospective cohort study.
    Osteoporos Int. 2021;32:565-573.
    PubMed     Abstract available


    February 2021
  273. GAO L, Jiao T, Feng Q, Wang W, et al
    Application of artificial intelligence in diagnosis of osteoporosis using medical images: a systematic review and meta-analysis.
    Osteoporos Int. 2021 Feb 27. pii: 10.1007/s00198-021-05887.
    PubMed     Abstract available


  274. CHOI YJ, Shin HB, Park B, Kim DJ, et al
    Temporal change in the diagnosis and treatment rates of osteoporosis: results from the Korea National Health and Nutrition Examination Survey.
    Osteoporos Int. 2021 Feb 25. pii: 10.1007/s00198-021-05864.
    PubMed     Abstract available



  275. Correction to: Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use.
    Osteoporos Int. 2021 Feb 24. pii: 10.1007/s00198-021-05883.
    PubMed    


  276. BERGMAN J, Nordstrom A, Hommel A, Kivipelto M, et al
    Correction to: Bisphosphonates and mortality: confounding in observational studies.
    Osteoporos Int. 2021 Feb 19. pii: 10.1007/s00198-021-05884.
    PubMed    


  277. SAAG K, Cosman F, De Villiers T, Langdahl B, et al
    Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysis.
    Osteoporos Int. 2021 Feb 19. pii: 10.1007/s00198-020-05785.
    PubMed     Abstract available


  278. HUANG X, Chen B, Thabane L, Adachi JD, et al
    Fragility of results from randomized controlled trials supporting the guidelines for the treatment of osteoporosis: a retrospective analysis.
    Osteoporos Int. 2021 Feb 17. pii: 10.1007/s00198-021-05865.
    PubMed     Abstract available


  279. YANG BR, Cha SH, Lee KE, Kim JW, et al
    Effect of dipeptidyl peptidase IV inhibitors, thiazolidinedione, and sulfonylurea on osteoporosis in patients with type 2 diabetes: population-based cohort study.
    Osteoporos Int. 2021 Feb 16. pii: 10.1007/s00198-020-05801.
    PubMed     Abstract available


  280. DRIESSEN JHM, van Dort MJ, Romme EAPM, Wouters EFM, et al
    Associations between bone attenuation and prevalent vertebral fractures on chest CT scans differ with vertebral fracture locations.
    Osteoporos Int. 2021 Feb 16. pii: 10.1007/s00198-020-05719.
    PubMed     Abstract available


  281. DELSMANN MM, Strahl A, Muhlenfeld M, Jandl NM, et al
    High prevalence and undertreatment of osteoporosis in elderly patients undergoing total hip arthroplasty.
    Osteoporos Int. 2021 Feb 11. pii: 10.1007/s00198-021-05881.
    PubMed     Abstract available


  282. HSU HE, Hsu YP, Yu CH
    Multiple vertebral compression fractures in a human immunodeficiency virus-positive patient with glucocorticoid-induced Cushing syndrome treated with percutaneous vertebroplasty: a case report.
    Osteoporos Int. 2021 Feb 11. pii: 10.1007/s00198-021-05880.
    PubMed     Abstract available


  283. ERWIN J, Enki DG, Woolf AD
    Younger people with rheumatoid arthritis are at increased risk of fracture even before age 50 years: a population-based cohort study.
    Osteoporos Int. 2021 Feb 11. pii: 10.1007/s00198-021-05862.
    PubMed     Abstract available


  284. MICHALSKI AS, Besler BA, Burt LA, Boyd SK, et al
    Opportunistic CT screening predicts individuals at risk of major osteoporotic fracture.
    Osteoporos Int. 2021 Feb 10. pii: 10.1007/s00198-021-05863.
    PubMed     Abstract available


  285. EASTMAN K, Gerlach M, Piec I, Greeves J, et al
    Effectiveness of parathyroid hormone (PTH) analogues on fracture healing: a meta-analysis.
    Osteoporos Int. 2021 Feb 9. pii: 10.1007/s00198-021-05847.
    PubMed     Abstract available


  286. SINGER AJ, Fuggle NR, Gill CB, Patel AR, et al
    COVID-19 and effects on osteoporosis management: the patient perspective from a National Osteoporosis Foundation survey.
    Osteoporos Int. 2021 Feb 8. pii: 10.1007/s00198-021-05836.
    PubMed    


  287. FUGGLE NR, Singer A, Gill C, Patel A, et al
    How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey.
    Osteoporos Int. 2021 Feb 8. pii: 10.1007/s00198-020-05793.
    PubMed     Abstract available


  288. CONSTABLE AM, Vlachopoulos D, Barker AR, Moore SA, et al
    The independent and interactive associations of physical activity intensity and vitamin D status with bone mineral density in prepubertal children: the PANIC Study.
    Osteoporos Int. 2021 Feb 5. pii: 10.1007/s00198-021-05872.
    PubMed     Abstract available


  289. KANIS JA, Johansson H, Harvey NC, Gudnason V, et al
    The effect on subsequent fracture risk of age, sex, and prior fracture site by recency of prior fracture.
    Osteoporos Int. 2021 Feb 4. pii: 10.1007/s00198-020-05803.
    PubMed     Abstract available


  290. MCCLOSKEY EV, Johansson H, Harvey NC, Lorentzon M, et al
    Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study.
    Osteoporos Int. 2021 Feb 3. pii: 10.1007/s00198-020-05815.
    PubMed     Abstract available


  291. ROBIN F, Cadiou S, Albert JD, Bart G, et al
    Methotrexate osteopathy: five cases and systematic literature review.
    Osteoporos Int. 2021;32:225-232.
    PubMed     Abstract available


    January 2021
  292. PLUSKIEWICZ W, Wilk R, Adamczyk P, Hajzyk M, et al
    The incidence of arm, forearm, and hip osteoporotic fractures during early stage of COVID-19 pandemic.
    Osteoporos Int. 2021 Jan 30. pii: 10.1007/s00198-020-05811.
    PubMed     Abstract available


  293. FRANCIOTTI R, Moharrami M, Quaranta A, Bizzoca ME, et al
    Use of fractal analysis in dental images for osteoporosis detection: a systematic review and meta-analysis.
    Osteoporos Int. 2021 Jan 28. pii: 10.1007/s00198-021-05852.
    PubMed     Abstract available


  294. CHANDRAN M, Mitchell PJ, Amphansap T, Bhadada SK, et al
    Development of the Asia Pacific Consortium on Osteoporosis (APCO) Framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region.
    Osteoporos Int. 2021 Jan 27. pii: 10.1007/s00198-020-05742.
    PubMed     Abstract available


  295. CRAWFORD-MANNING F, Greenall C, Hawarden A, Bullock L, et al
    Evaluation of quality and readability of online patient information on osteoporosis and osteoporosis drug treatment and recommendations for improvement.
    Osteoporos Int. 2021 Jan 27. pii: 10.1007/s00198-020-05800.
    PubMed     Abstract available


  296. PAUL J, Devarapalli V, Johnson JT, Cherian KE, et al
    Do proximal hip geometry, trabecular microarchitecture, and prevalent vertebral fractures differ in postmenopausal women with type 2 diabetes mellitus? A cross-sectional study from a teaching hospital in southern India.
    Osteoporos Int. 2021 Jan 27. pii: 10.1007/s00198-021-05855.
    PubMed     Abstract available


  297. SAHOTA O, van Berkel D, Ong T, Drummond A, et al
    Pelvic fragility fractures-the forgotten osteoporotic fracture!
    Osteoporos Int. 2021 Jan 25. pii: 10.1007/s00198-021-05848.
    PubMed    


  298. OSAKI M, Okuda R, Saeki Y, Okano T, et al
    Efficiency of coordinator-based osteoporosis intervention in fragility fracture patients: a prospective randomized trial.
    Osteoporos Int. 2021 Jan 23. pii: 10.1007/s00198-021-05825.
    PubMed     Abstract available


  299. IBRAHIMAGIC OC, Vujadinovic A, Ercegovic Z, Kunic S, et al
    Comment on an article: "Osteoporosis in the age of COVID-19 patients".
    Osteoporos Int. 2021 Jan 21. pii: 10.1007/s00198-020-05607.
    PubMed    


  300. HOFF M, Skovlund E, Meyer HE, Langhammer A, et al
    Does treatment with bisphosphonates protect against fractures in real life? The HUNT study, Norway.
    Osteoporos Int. 2021 Jan 21. pii: 10.1007/s00198-021-05845.
    PubMed     Abstract available


  301. LEMS WF, Paccou J, Zhang J, Fuggle NR, et al
    Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services.
    Osteoporos Int. 2021 Jan 21. pii: 10.1007/s00198-020-05804.
    PubMed     Abstract available


  302. GOU P, Wang Z, Zhao Z, Wang Y, et al
    Restoration of the intravertebral stability in Kummell's disease following the treatment of severe postmenopausal osteoporosis by 1-34PTH-a retrospective study.
    Osteoporos Int. 2021 Jan 20. pii: 10.1007/s00198-020-05761.
    PubMed     Abstract available


  303. WANDELL P, Li X, Carlsson AC, Sundquist J, et al
    Osteoporotic fractures in second-generation immigrants and Swedish natives.
    Osteoporos Int. 2021 Jan 19. pii: 10.1007/s00198-020-05776.
    PubMed     Abstract available


  304. LUCASSEN MJJ, Ter Wee MM, den Uyl D, Konijn NPC, et al
    Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trial.
    Osteoporos Int. 2021 Jan 19. pii: 10.1007/s00198-020-05781.
    PubMed     Abstract available


  305. LU K, Yin Y, Li C, Jin Y, et al
    Efficacy of annual zoledronic acid in initial percutaneous kyphoplasty patients with osteoporotic vertebral compression fractures: a 3-year follow-up study.
    Osteoporos Int. 2021 Jan 18. pii: 10.1007/s00198-020-05816.
    PubMed     Abstract available


  306. LIU CS, Feasel AL, Kline GA, Billington EO, et al
    Pharmacotherapy decisions among postmenopausal women attending a group medical consultation or a one-on-one specialist consultation at an osteoporosis center: an observational cohort study.
    Osteoporos Int. 2021 Jan 18. pii: 10.1007/s00198-021-05823.
    PubMed     Abstract available


  307. GUANABENS N, Olmos JM, Hernandez JL, Cerda D, et al
    Vertebral fractures are increased in rheumatoid arthritis despite recent therapeutic advances: a case-control study.
    Osteoporos Int. 2021 Jan 18. pii: 10.1007/s00198-021-05824.
    PubMed     Abstract available


  308. POWELL J, Michael A
    Peri-operative derangement in liver function tests in older patients with neck of femur fracture.
    Osteoporos Int. 2021 Jan 18. pii: 10.1007/s00198-021-05827.
    PubMed     Abstract available


  309. HILIGSMANN M, Maggi S, Veronese N, Sartori L, et al
    Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy.
    Osteoporos Int. 2021 Jan 14. pii: 10.1007/s00198-020-05802.
    PubMed     Abstract available


  310. WU YF, Lu K, Girgis C, Preda M, et al
    Postpartum bilateral sacral stress fracture without osteoporosis-a case report and literature review.
    Osteoporos Int. 2021 Jan 13. pii: 10.1007/s00198-020-05788.
    PubMed     Abstract available


  311. XU F, Zhang Q, Wang LK, Tang QX, et al
    Estimates of the effects of physical activity on osteoporosis using multivariable Mendelian randomization analysis.
    Osteoporos Int. 2021 Jan 13. pii: 10.1007/s00198-020-05786.
    PubMed     Abstract available


  312. BILLINGTON EO, Leslie WD, Brown JP, Prior JC, et al
    Simulated effects of early menopausal bone mineral density preservation on long-term fracture risk: a feasibility study.
    Osteoporos Int. 2021 Jan 12. pii: 10.1007/s00198-021-05826.
    PubMed     Abstract available


  313. DE VRIES BCS, Hegeman JH, Nijmeijer W, Geerdink J, et al
    Comparing three machine learning approaches to design a risk assessment tool for future fractures: predicting a subsequent major osteoporotic fracture in fracture patients with osteopenia and osteoporosis.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05735.
    PubMed     Abstract available


  314. XU X, Zhang M, Fei Z, Sheng H, et al
    Calcification of lower extremity arteries is related to the presence of osteoporosis in postmenopausal women with type 2 diabetes mellitus: a cross-sectional observational study.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05775.
    PubMed     Abstract available


  315. TRAN O, Silverman S, Xu X, Bonafede M, et al
    Long-term direct and indirect economic burden associated with osteoporotic fracture in US postmenopausal women.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05769.
    PubMed     Abstract available


  316. SORESKOG E, Borgstrom F, Lindberg I, Strom O, et al
    A novel economic framework to assess the cost-effectiveness of bone-forming agents in the prevention of fractures in patients with osteoporosis.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05765.
    PubMed     Abstract available


  317. HANS D, Shevroja E, Leslie WD
    Evolution in fracture risk assessment: artificial versus augmented intelligence.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05737.
    PubMed    


  318. YU WY, Hwang HF, Chen CY, Lin MR, et al
    Situational risk factors for fall-related vertebral fractures in older men and women.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05799.
    PubMed     Abstract available


  319. HAYES KN, He N, Brown KA, Cheung AM, et al
    Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05794.
    PubMed     Abstract available


  320. ZHANG Z, Zhou X, Shu L, Hu M, et al
    The association between overweight/obesity and vertebral fractures in older adults: a meta-analysis of observational studies.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05764.
    PubMed     Abstract available


  321. ICONARU L, Moreau M, Baleanu F, Kinnard V, et al
    Risk factors for imminent fractures: a substudy of the FRISBEE cohort.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05772.
    PubMed     Abstract available


  322. SOLLING AS, Christensen DH, Darvalics B, Harslof T, et al
    Fracture rates in patients discontinuing alendronate treatment in real life: a population-based cohort study.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05745.
    PubMed     Abstract available


  323. SORESKOG E, Lindberg I, Kanis JA, Akesson KE, et al
    Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden.
    Osteoporos Int. 2021 Jan 6. pii: 10.1007/s00198-020-05780.
    PubMed     Abstract available


  324. ZHOU H, Li C, Song W, Wei M, et al
    Increasing fasting glucose and fasting insulin associated with elevated bone mineral density-evidence from cross-sectional and MR studies.
    Osteoporos Int. 2021 Jan 6. pii: 10.1007/s00198-020-05762.
    PubMed     Abstract available


  325. ZHU Q, Xu J, Zhou M, Lian X, et al
    Association between type 1 diabetes mellitus and reduced bone mineral density in children: a meta-analysis.
    Osteoporos Int. 2021 Jan 6. pii: 10.1007/s00198-020-05715.
    PubMed     Abstract available


  326. WU Y, Wang F, Zhang Z
    The efficacy and safety of bisphosphonate analogs for treatment of osteoporosis after spinal cord injury: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2021 Jan 2. pii: 10.1007/s00198-020-05807.
    PubMed     Abstract available


  327. SAPKOTA HR, Nune A, Bateman J, Venkatachalam S, et al
    A pragmatic proposal for triaging DXA testing during the COVID-19 global pandemic.
    Osteoporos Int. 2021;32:1-6.
    PubMed     Abstract available


    December 2020
  328. KRISTJANSDOTTIR HL, Mellstrom D, Johansson P, Karlsson M, et al
    High platelet count is associated with low bone mineral density: The MrOS Sweden cohort.
    Osteoporos Int. 2020 Dec 11. pii: 10.1007/s00198-020-05766.
    PubMed     Abstract available


  329. BURDEN AM, Tanaka Y, Xu L, Ha YC, et al
    Osteoporosis case ascertainment strategies in European and Asian countries: a comparative review.
    Osteoporos Int. 2020 Dec 10. pii: 10.1007/s00198-020-05756.
    PubMed     Abstract available



  330. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Author Index.
    Osteoporos Int. 2020;31.
    PubMed    



  331. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Satellite Symposia Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  332. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Poster Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  333. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Non-Sponsored Symposia Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  334. World congress on osteoporosis, osteoarthritis and musculoskeletal diseases (WCO-IOF-ESCEO 2020): Committee of Scientific Advisors Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  335. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Committee of National Societies Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  336. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Meet-The-Experts Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  337. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): ESPRM-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  338. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): EUGMS-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  339. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): ESCEO-WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging Symposium Abstracts (ESCEO-WHOCC).
    Osteoporos Int. 2020;31.
    PubMed    



  340. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): ESCEO-IOF Symposia Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  341. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): ESCEO Symposium Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  342. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Oral Communications Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  343. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Plenary Lectures Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  344. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Educational Lecture Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  345. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Special Lecture Abstract.
    Osteoporos Int. 2020;31.
    PubMed    



  346. WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
    Osteoporos Int. 2020;31.
    PubMed    


  347. CAMPONOVO C, Aubry-Rozier B, Lamy O, Gonzalez Rodriguez E, et al
    Hypercalcemia upon denosumab withdrawal in primary hyperparathyroidism: a case report and literature review.
    Osteoporos Int. 2020;31:2485-2491.
    PubMed     Abstract available


  348. ABDALA R, Levi L, Longobardi V, Zanchetta MB, et al
    Severe bone microarchitecture deterioration in a family with hereditary neuropathy: evidence of the key role of the mechanostat.
    Osteoporos Int. 2020;31:2477-2480.
    PubMed     Abstract available


  349. IMEL EA, Starzyk K, Gliklich R, Weiss RJ, et al
    Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis.
    Osteoporos Int. 2020;31:2413-2424.
    PubMed     Abstract available


    November 2020
  350. DAHL C, Madsen C, Omsland TK, Sogaard AJ, et al
    Contribution of elevation and residential proximity to the coast in explaining geographic variations in hip fracture incidence. A Norwegian Epidemiologic Osteoporosis Studies (NOREPOS) study.
    Osteoporos Int. 2020 Nov 27. pii: 10.1007/s00198-020-05736.
    PubMed     Abstract available


  351. OZAKI D, Kubota R, Maeno T, Abdelhakim M, et al
    Association between gut microbiota, bone metabolism, and fracture risk in postmenopausal Japanese women.
    Osteoporos Int. 2020 Nov 25. pii: 10.1007/s00198-020-05728.
    PubMed     Abstract available


  352. NING HT, Du Y, Zhao LJ, Tian Q, et al
    Racial and gender differences in the relationship between sarcopenia and bone mineral density among older adults.
    Osteoporos Int. 2020 Nov 24. pii: 10.1007/s00198-020-05744.
    PubMed     Abstract available


  353. LANE NE, Saag K, O'Neill TJ, Manion M, et al
    Real-world bone turnover marker use: impact on treatment decisions and fracture.
    Osteoporos Int. 2020 Nov 24. pii: 10.1007/s00198-020-05734.
    PubMed     Abstract available


  354. MIN C, Yoo DM, Wee JH, Lee HJ, et al
    High-Intensity Physical Activity with High Serum Vitamin D Levels is Associated with a Low Prevalence of Osteopenia and Osteoporosis: A Population-Based Study.
    Osteoporos Int. 2020 Nov 23. pii: 10.1007/s00198-020-05746.
    PubMed     Abstract available


  355. BINKLEY N, Orwoll E, Chapurlat R, Langdahl BL, et al
    Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosis.
    Osteoporos Int. 2020 Nov 17. pii: 10.1007/s00198-020-05701.
    PubMed     Abstract available


  356. ONG T, Copeland R, Thiam CN, Cerda Mas G, et al
    Integration of a vertebral fracture identification service into a fracture liaison service: a quality improvement project.
    Osteoporos Int. 2020 Nov 10. pii: 10.1007/s00198-020-05710.
    PubMed     Abstract available


  357. TANG C, Zhang W, Li H, Li L, et al
    CNN-based qualitative detection of bone mineral density via diagnostic CT slices for osteoporosis screening.
    Osteoporos Int. 2020 Nov 9. pii: 10.1007/s00198-020-05673.
    PubMed     Abstract available


  358. NG CA, McMillan LB, Humbert L, Ebeling PR, et al
    Feasibility, safety and effectiveness of a pilot 16-week home-based, impact exercise intervention in postmenopausal women with low bone mineral density.
    Osteoporos Int. 2020 Nov 7. pii: 10.1007/s00198-020-05723.
    PubMed     Abstract available


  359. KANIS JA, Harvey NC, Lorentzon M, Liu E, et al
    Combining fracture outcomes in phase 3 trials of osteoporosis: an analysis of the effects of denosumab in postmenopausal women.
    Osteoporos Int. 2020 Nov 6. pii: 10.1007/s00198-020-05699.
    PubMed     Abstract available


  360. LEE JW, Min C, Bang CH, Kwon BC, et al
    Psoriasis is associated with an increased risk of osteoporosis: follow-up and nested case-control studies using a national sample cohort.
    Osteoporos Int. 2020 Nov 5. pii: 10.1007/s00198-020-05724.
    PubMed     Abstract available


  361. KANIS JA, Cooper C, Dawson-Hughes B, Harvey NC, et al
    FRAX and ethnicity.
    Osteoporos Int. 2020;31:2063-2067.
    PubMed    


    October 2020
  362. RANGANATH LR, Khedr M, Vinjamuri S, Gallagher JA, et al
    Frequency, diagnosis, pathogenesis and management of osteoporosis in alkaptonuria: data analysis from the UK National Alkaptonuria Centre.
    Osteoporos Int. 2020 Oct 29. pii: 10.1007/s00198-020-05671.
    PubMed     Abstract available


  363. RIKKONEN T, Sund R, Sirola J, Honkanen R, et al
    Obesity is associated with early hip fracture risk in postmenopausal women: a 25-year follow-up.
    Osteoporos Int. 2020 Oct 23. pii: 10.1007/s00198-020-05665.
    PubMed     Abstract available


  364. LARSSON BAM, Johansson L, Johansson H, Axelsson KF, et al
    The timed up and go test predicts fracture risk in older women independently of clinical risk factors and bone mineral density.
    Osteoporos Int. 2020 Oct 21. pii: 10.1007/s00198-020-05681.
    PubMed     Abstract available


  365. KANIS JA, Johansson H, Harvey NC, Gudnason V, et al
    The use of 2-, 5-, and 10-year probabilities to characterize fracture risk after a recent sentinel fracture.
    Osteoporos Int. 2020 Oct 20. pii: 10.1007/s00198-020-05700.
    PubMed     Abstract available


  366. ASANO Y, Tajiri K, Yagishita S, Nakanishi H, et al
    Correction to: Bilateral atypical ulnar fractures occurring after long-term treatment with bisphosphonate for 7 years and with teriparatide for 2 years: a case report.
    Osteoporos Int. 2020 Oct 20. pii: 10.1007/s00198-020-05679.
    PubMed     Abstract available


  367. MCCLOSKEY EV, Harvey NC, Johansson H, Lorentzon M, et al
    Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures.
    Osteoporos Int. 2020 Oct 14. pii: 10.1007/s00198-020-05542.
    PubMed     Abstract available


  368. LAROCHE M, Champs B, Couture G, Degboe Y, et al
    Consequence of vertebral fracture cascades: about a cohort of 79 patients.
    Osteoporos Int. 2020 Oct 14. pii: 10.1007/s00198-020-05581.
    PubMed    


  369. DOMICIANO DS, Machado LG, Figueiredo CP, Caparbo VF, et al
    Incidence and risk factors for osteoporotic non-vertebral fracture in low-income community-dwelling elderly: a population-based prospective cohort study in Brazil. The Sao Paulo Ageing and Health (SPAH) study.
    Osteoporos Int. 2020 Oct 10. pii: 10.1007/s00198-020-05669.
    PubMed     Abstract available


  370. RONN SH, Harslof T, Oei L, Pedersen SB, et al
    The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial.
    Osteoporos Int. 2020 Oct 8. pii: 10.1007/s00198-020-05638.
    PubMed     Abstract available


  371. CUNDY T
    Treat-to-target-mainstream or marketing?
    Osteoporos Int. 2020;31:1835-1836.
    PubMed    


    September 2020
  372. ZHU K, Zhang J, Zhang C, Zhao Z, et al
    Therapeutic efficacy of zoledronic acid combined with calcitriol in elderly patients receiving total hip arthroplasty or hemiarthroplasty for osteoporotic femoral neck fracture.
    Osteoporos Int. 2020 Sep 28. pii: 10.1007/s00198-020-05637.
    PubMed     Abstract available


  373. LEWIECKI EM, Wright NC, Singer AJ
    Racial disparities, FRAX, and the care of patients with osteoporosis.
    Osteoporos Int. 2020 Sep 26. pii: 10.1007/s00198-020-05655.
    PubMed    


  374. TOMINAGA A, Wada K, Kato Y, Nishi H, et al
    Early clinical effects, safety, and appropriate selection of bone markers in romosozumab treatment for osteoporosis patients: a 6-month study.
    Osteoporos Int. 2020 Sep 26. pii: 10.1007/s00198-020-05639.
    PubMed     Abstract available


  375. GOMES-FERREIRA PHS, de Oliveira D, Frigerio PB, de Souza Batista FR, et al
    Teriparatide improves microarchitectural characteristics of peri-implant bone in orchiectomized rats.
    Osteoporos Int. 2020;31:1807-1815.
    PubMed     Abstract available


  376. CLYNES MA, Westbury LD, Dennison EM, Kanis JA, et al
    Bone densitometry worldwide: a global survey by the ISCD and IOF.
    Osteoporos Int. 2020;31:1779-1786.
    PubMed     Abstract available


    July 2020
  377. FU Y, Li C, Luo W, Chen Z, et al
    Fragility fracture discriminative ability of radius quantitative ultrasound: a systematic review and meta-analysis.
    Osteoporos Int. 2020 Jul 30. pii: 10.1007/s00198-020-05559.
    PubMed     Abstract available


    June 2020
  378. SALE JEM, Frankel L, Bogoch E, Gignac M, et al
    Few fragility fracture patients perceive that their bone health is affected by their comorbidities and medications.
    Osteoporos Int. 2020 Jun 5. pii: 10.1007/s00198-020-05409.
    PubMed     Abstract available


  379. CUMMINGS SR, McCulloch C
    Explanations for the difference in rates of cardiovascular events in a trial of alendronate and romosozumab.
    Osteoporos Int. 2020;31:1019-1021.
    PubMed    


    May 2020
  380. WHITTIER DE, Boyd SK, Burghardt AJ, Paccou J, et al
    Guidelines for the assessment of bone density and microarchitecture in vivo using high-resolution peripheral quantitative computed tomography.
    Osteoporos Int. 2020 May 26. pii: 10.1007/s00198-020-05438.
    PubMed     Abstract available


  381. VAN DEN BERG P, van Haard PMM, Geusens PP, van den Bergh JP, et al
    Characterization of fracture liaison service non-responders after invitation by home visits and questionnaires.
    Osteoporos Int. 2020 May 13. pii: 10.1007/s00198-020-05442.
    PubMed     Abstract available


    April 2020
  382. LIU Y, Dash A, Krez A, Kim HJ, et al
    Low volumetric bone density is a risk factor for early complications after spine fusion surgery.
    Osteoporos Int. 2020;31:647-654.
    PubMed     Abstract available


  383. VAN BODEGRAVEN AA, Bravenboer N
    Perspective on skeletal health in inflammatory bowel disease.
    Osteoporos Int. 2020;31:637-646.
    PubMed     Abstract available


  384. GEIKER NRW, Molgaard C, Iuliano S, Rizzoli R, et al
    Impact of whole dairy matrix on musculoskeletal health and aging-current knowledge and research gaps.
    Osteoporos Int. 2020;31:601-615.
    PubMed     Abstract available


  385. VIETH R
    Weaker bones and white skin as adaptions to improve anthropological "fitness" for northern environments.
    Osteoporos Int. 2020;31:617-624.
    PubMed     Abstract available


    March 2020
  386. CHEN YJ, Kung PT, Chou WY, Tsai WC, et al
    Alendronate medication possession ratio and the risk of second hip fracture: an 11-year population-based cohort study in Taiwan.
    Osteoporos Int. 2020 Mar 27. pii: 10.1007/s00198-020-05399.
    PubMed     Abstract available


  387. GRIZZO FMF, Alarcao ACJ, Dell' Agnolo CM, Pedroso RB, et al
    How does women's bone health recover after lactation? A systematic review and meta-analysis.
    Osteoporos Int. 2020;31:413-427.
    PubMed     Abstract available


  388. OHBAYASHI Y, Iwasaki A, Nakai F, Mashiba T, et al
    A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration.
    Osteoporos Int. 2020;31:577-585.
    PubMed     Abstract available


    February 2020
  389. HOLLICK RJ, McKee L, Shim J, Ramsay N, et al
    Introducing mobile fracture prevention services with DXA in Northern Scotland: a comparative study of three rural communities.
    Osteoporos Int. 2020 Feb 21. pii: 10.1007/s00198-020-05316.
    PubMed     Abstract available


  390. ALARCON T, Ojeda-Thies C, Saez-Lopez P, Gomez-Campelo P, et al
    Usefulness of a national hip fracture registry to evaluate the profile of patients in whom antiosteoporotic treatment is prescribed following hospital discharge.
    Osteoporos Int. 2020 Feb 20. pii: 10.1007/s00198-020-05341.
    PubMed     Abstract available


  391. LAU EMC, Dinavahi R, Woo YC, Wu CH, et al
    Romosozumab or alendronate for fracture prevention in East Asian patients: a subanalysis of the phase III, randomized ARCH study.
    Osteoporos Int. 2020 Feb 11. pii: 10.1007/s00198-020-05324.
    PubMed     Abstract available


    January 2020
  392. RUIZ-ADAME M, Correa M
    A systematic review of the indirect and social costs studies in fragility fractures.
    Osteoporos Int. 2020 Jan 30. pii: 10.1007/s00198-020-05319.
    PubMed     Abstract available


  393. MUGNIER B, Daumas A, Doddoli S, Belmeliani S, et al
    Adherence to fracture liaison service programs in patients over 70: the hidden part of the iceberg.
    Osteoporos Int. 2020 Jan 11. pii: 10.1007/s00198-020-05290.
    PubMed     Abstract available


  394. CHIU WY, Lin CJ, Yang WS, Tsai KS, et al
    Racial difference in bioavailability of oral ibandronate between Caucasian and Taiwanese postmenopausal women.
    Osteoporos Int. 2020;31:193-201.
    PubMed     Abstract available


    December 2019
  395. RASMUSSEN NH, Dal J, de Vries F, van den Bergh JP, et al
    Diabetes and fractures: new evidence of atypical femoral fractures?
    Osteoporos Int. 2019 Dec 14. pii: 10.1007/s00198-019-05224.
    PubMed     Abstract available


  396. EBELING PR, Chan DC, Lau TC, Lee JK, et al
    Secondary prevention of fragility fractures in Asia Pacific: an educational initiative.
    Osteoporos Int. 2019 Dec 1. pii: 10.1007/s00198-019-05197.
    PubMed     Abstract available


    September 2019
  397. GONZALEZ-QUEVEDO D, Bautista-Enrique D, Perez-Del-Rio V, Bravo-Bardaji M, et al
    Fracture liaison service and mortality in elderly hip fracture patients: a prospective cohort study.
    Osteoporos Int. 2019 Sep 11. pii: 10.1007/s00198-019-05153.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: